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Formulation of a High-Volume Small Molecule Drug Product
Abstract
Small molecule drug products play an enormous role in innovative treatments for a vast number of
diseases and have comprised most annual FDA drug approvals each year to date. Thus, economically
efficient mass production of small molecule drugs is an essential public health concern. While batch
production of these types of pharmaceuticals dominates the industry, continuous manufacturing has
emerged as a promising technology with positive economic implications. However, due to the newness of
the technology, pharmaceutical companies have been reluctant to adopt continuous manufacturing. This
project presents a full economic evaluation of batch versus continuous manufacturing of a high-volume
small molecule drug product through ground-up design of production facilities and a target cost of
conversion of one cent per tablet. The production of tablets from API (active pharmaceutical ingredient)
is broken down into six different unit-operations—granulation, drying, milling, blending, compression, and
coating. The batch and continuous processes are designed at the unit-operation level to determine
equipment and utility costs, allowing for a rigorous profitability analysis. It was determined that the
continuous manufacturing process is more profitable than the batch process. For a cost of conversion of
one cent per tablet and a 21-year plant life, the batch process had an internal rate of return (IRR) of -0.3%
and return on investment (ROI) of -2.4%, while the continuous process had an IRR of 8.4% and ROI of
2.7%. Further analysis showed that increasing the cost of conversion to two cents per tablet resulted in an
IRR of 26% and ROI of 17% for the batch process and an IRR of 37% and an ROI of 28% for the continuous
process. Increasing the cost of conversion confirms that the continuous process is more profitable than
the batch process.
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The following report contains designs for batch and continuous processes and
manufacturing facilities for both processes to manufacture a small molecule drug product known
as Clairatenol. Anticipated sales are 1 billion tablets per year, and the target cost of conversion is
$0.01. Both processes include six unit-operations—granulation, drying, milling, blending,
compression, and coating.
Economic analyses were completed for both processes. The batch manufacturing plant
had a return on investment of -2.4%, and an internal rate of return of -0.3%. The continuous
plant, on the other hand, had a return on investment of 2.7% and an internal rate of return of
8.4%. These results show the potential of using continuous manufacturing as a more efficient and
profitable alternative to batch manufacturing for producing small molecule drug products.
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continuous process is consistently more profitable than the batch process. Consequently, we
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Section 1: Abstract
Small molecule drug products play an enormous role in innovative treatments for a vast
number of diseases and have comprised most annual FDA drug approvals each year to date.
Thus, economically efficient mass production of small molecule drugs is an essential public
health concern. While batch production of these types of pharmaceuticals dominates the industry,
continuous manufacturing has emerged as a promising technology with positive economic
implications. However, due to the newness of the technology, pharmaceutical companies have
been reluctant to adopt continuous manufacturing. This project presents a full economic
evaluation of batch versus continuous manufacturing of a high-volume small molecule drug
product through ground-up design of production facilities and a target cost of conversion of one
cent per tablet. The production of tablets from API (active pharmaceutical ingredient) is broken
down into six different unit-operations—granulation, drying, milling, blending, compression, and
coating. The batch and continuous processes are designed at the unit-operation level to determine
equipment and utility costs, allowing for a rigorous profitability analysis. It was determined that
the continuous manufacturing process is more profitable than the batch process. For a cost of
conversion of one cent per tablet and a 21-year plant life, the batch process had an internal rate
of return (IRR) of -0.3% and return on investment (ROI) of -2.4%, while the continuous process
had an IRR of 8.4% and ROI of 2.7%. Further analysis showed that increasing the cost of
conversion to two cents per tablet resulted in an IRR of 26% and ROI of 17% for the batch
process and an IRR of 37% and an ROI of 28% for the continuous process. Increasing the cost of
conversion confirms that the continuous process is more profitable than the batch process.
Disciplines
Biochemical and Biomolecular Engineering | Chemical Engineering | Engineering
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Section 2: Introduction and Objective Time Chart
Section 2.1 Project Background
Small molecule drug products are defined as any organic compounds with low molecular
weight that are manufactured through chemical synthesis and include most patented medicines
on the market [61]. Small molecule drug products can be formulated as oral solid dosage forms,
and this includes tablets and capsules that are efficient and cost-effective to manufacture and
easy to administer [29]. Active Pharmaceutical Ingredients (APIs) are pharmaceutically active
bulk drugs that induce a desired pharmacological effect and are formulated into small molecule
drug products such as tablets and capsules. These small molecule drug products also contain
excipients, which are inactive substances usually used as a carrier of the API in the drug. The
functionality of excipients includes providing bulkiness to formulations, facilitating absorption
of the drug, and providing stability and preventing denaturation of drugs [47]. There are many
different types of excipients—binders, disintegrants, lubricants, colorants, and glidants [19].
Binders, such as microcrystalline cellulose, provide mechanical strength and form to the tablet as
they hold together the API and excipients in the tablet [24]. Disintegrants accelerate the
breakdown of the tablet in the body, and subsequently improve the oral bioavailability— the
fraction of drug dosage that reaches the therapeutic site of action in the body—of the drug in the
body [58]. Lubricants, such as magnesium stearate, prevent the tablets from adhering to the
tablet press during compression. Colorants are used to make the drugs more recognizable for
patients. Lastly, glidants help in improving powder flow by reducing friction and adhesion
between particles [24].
Small molecule APIs can be formulated through two manufacturing processes—batch
and continuous. During a batch process, there is a pause between each step as a batch moves

9

through. Continuous manufacturing is an uninterrupted, nonstop process from the start until the
product is completed. Batch manufacturing is more common in the pharmaceutical industry and
thus considered to be more reliable. However, continuous manufacturing has become more
popular in the pharmaceutical industry due to advantages inherent to continuous manufacturing
for high volume products. Continuous manufacturing is faster than batch manufacturing.
Additionally, continuous manufacturing can be safer as it eliminates steps involving human
intervention and significantly reduces the risk of error. Furthermore, continuous manufacturing
can be cheaper after initial investment. According to the National Science and Technology
Council, drug makers who implement continuous manufacturing could save between 40 and 50
percent in variable costs compared to batch manufacturing [35]. The purpose of this project is to
determine which design process would be more profitable and determine if the pharmaceutical
industry would benefit from adopting continuous process design more frequently.

Section 2.2 Project Goals
This report focuses on determining whether a batch or a continuous manufacturing
facility would be more economical for formulating a small molecule drug product. For this
project, our goal is to design both batch and continuous processes to formulate a blockbuster
drug product called Clairatenol and design manufacturing facilities for producing this drug by
both processes. To design our manufacturing facilities, we have anticipated sales of 1 billion
tablets per year, with a goal cost of conversion into tablets of 1 cent per tablet.
The chemical make-up of Clairatenol is classified, and the specific formulation of this
drug cannot be discussed in this report. As a result, this drug is treated as a generic drug and the
process is designed to be universal so that it can be used to produce different types of drugs. For
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the analysis, a drug with the following make-up is used as a model—50% AP1, 26% excipients
added during first blending, 2% binding, 18% excipients added during second blending and 4%
coating.

Section 2.3 Production Goals
Both plants will be operating for 330 days per year for 24 hours. For the evaluation, a
model drug of 325mg API with 50% drug load (650 mg/tablet) will be used to design both
processes. However, both processes are designed to have the ability to produce drugs of varying
shape, weight, dosage, and coating composition. To achieve the goal of producing 1 billion
tablets per year with the model drug, the production facility needs to produce 650,000 kg/yr. For
the batch process, the design facility needs to produce one 1970 kg batch per day to meet the
production target. 2000 kg per batch per day is taken as the batch size for simplicity in
calculations. The resulting mass of tablets produced per year for a 2000 kg batch per day is
660,000 kg/yr. It should be noted that for all subsequent calculations for the batch process, the
output per year is taken as 660,000 kg/yr. For the continuous process, the design facility needs to
have a throughput of 82 kg/hr.

Section 2.4 Design Process
For this report, we will be evaluating which process is more profitable using economic
analyses. Both processes include the following unit operations—blending, granulation, drying,
milling, compression, and coating.
Blending is a unit operation that occurs twice in the process design. First, there is an
initial blending that occurs before granulation. Blending occurs once more after milling and
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before compression. During blending, the API and excipients are blended to obtain a
homogenized product with three mechanisms of mixing—diffusion, convection, and shear. A bin
blender is used for the batch design, and a continuous blender is used for the continuous design.
The next unit operation is granulation, which is followed by drying. During granulation,
the particles are enlarged as powder particles are agglomerated while retaining the integrity of
the original particles [52]. The powder formulation is a combination of the API and excipients.
The excipients are important as they influence specific physical (size and flowability) and
mechanical (hardness or deformability) behaviors. During this operation, fine powders are
transformed into free-flowing dust particles that can be more easily compressed. For this design,
a top-spray fluid bed granulator is used for the batch process in a vessel that incorporates both
granulation and drying. For the continuous design, a twin-screw granulator and a continuous
fluid bed dryer are used.
Milling is the unit operation that occurs after granulation and drying. During milling,
large clumps of the material are deagglomerated to achieve a more uniform particle size
distribution. Milling contributes to improving drug dissolution and solubility [31]. This is a semicontinuous process, so the same type of mill can be used for both designs. For both designs, a
Quadro FlexSift S20 will be used as it screens for impurities and successfully breaks down
particle clumps before the second blending operation.
During compression, which occurs after the second blending step, a blend of powders
containing pharmaceutical excipients and API are compressed into tablets. Tablet presses operate
as a continuous process. Both batch and continuous process will utilize a continuous tablet press
called a rotary tablet press.
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The final unit operation for our design is tablet coating. The application of a coating gives
the tablets the required appearance. There are different types of tablet coating solutions used to
enhance specific functionality such as concealing bitter taste, creating smooth coverings to
facilitate swallowing, protect the pill from damage due to external forces, and for branding. For
our process designs, we use a fully perforated pan for the batch design and a shallower fully
perforated pan for the continuous process.

Section 2.5 Project Deliverables
For this report, economic comparison of the two processes is the main deliverable and
will be used to determine which process—batch or continuous—is a wiser investment. A
complete profitability analysis was performed for both processes to determine which design
process is more profitable. In Section 21, the economic analysis is discussed in detail.
Throughout the development of the design of both manufacturing processes, assumptions were
made that will be detailed throughout the report.
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Section 2.6 Project Time Chart
Week 1

Week 2

Week 3

Week 4
Complete
preliminary research

January
February Material Balances

Energy Balances

Research on Specific
unit operations
Modelling processes
in SuperPro Designer

March

Selection of specific
equipment for each unit
operation

Completion of
Models in SuperPro
Designer
Mid-Semester
Presentation

April

Complete Economic
Evaluation

Purchase Costs
Reach out to
equipment
vendors
Submit final
draft of report

Final Presentation
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Section 4: Market and Competitive Analyses
It is well established that the global pharmaceutical manufacturing market is one of the
largest and most rapidly growing in the world, with its epicenter located in the United States. In
2020, the pharmaceutical manufacturing market was valued at $405.52 billion USD and
projected to grow at a compound annual growth rate of 13.7% [45]. The catalysts for growth in
this market include consistent rises in R&D spending, advancements in technology, the rising
focus on healthcare needs, growth of the geriatric population, the incidence rate of chronic
disorders, increasing rate of FDA approvals, and generous healthcare legislation. In response to
increasing demand for pharmaceuticals, manufacturers have been racing to explore more
efficient means of production. This has led to an increased interest in continuous pharmaceutical
manufacturing.
Pharmaceutical drugs can be split into two categories—biologics and small molecule
drugs. While the market for biologics is growing rapidly, continuous manufacture of these types
of pharmaceuticals is not yet possible and therefore will not be further discussed in this report.
While greater emphasis has recently been placed on biologics, small molecule drugs still account
for 90% of global drug sales [61]. Since 2015, four key players in the market—Vertex, Janssen,
Eli Lilly & Co., and Pfizer—have adopted continuous manufacturing for at least one small
molecule drug product, as shown in Table 4.1 [15].
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Table 4.1: FDA Approved Drugs Manufactured Continuously as of 2021
Approval Date

Company

Product

Treatment

July 2015

Vertex

Orkambi

Cystic Fibrosis

April 2016

Janssen

Prezista

HIV

September 2017

Eli Lilly & Co.

Verezino

Breast Cancer

February 2018

Vertex

Symdeko

Cystic Fibrosis

November 2018

Pfizer

Daurismo

Acute myeloid leukemia

While the majority of small molecule drugs are produced using batch manufacturing, the
adoption of continuous manufacturing by large companies reflects growing interest in the
process and potential for greater future incorporation. However, this transition from a wellestablished process to a new one requires great investment due to new start-up costs and costs
associated with the difficulty of paving the way for a newer technology, including longer
approval times and definition of new regulations. It has been observed that the majority of
companies who have adopted this continuous form of pharmaceutical manufacturing have been
motivated by future payoffs and a desire for innovation, rather than practical economic realities
[52]. Additionally, Vertex has fallen under scrutiny for its pricing of Orkambi by the public,
which is likely higher as a result of increased costs due to the start-up of a new continuous
manufacturing facility [23]. While it may be difficult to motivate a company currently producing
a small molecule product to switch from batch to continuous modes of production, the target
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market for such technologies lies in scenarios where a company is looking to begin production of
a new drug and is willing to invest in a brand-new facility.
Despite initial economic deterrents, there is great support from the FDA and the
pharmaceutical community to invest in continuous manufacturing as well as many projected
economic and societal benefits. Janet Woodcock, Acting Commissioner of the FDA, has publicly
announced an eagerness to partner with industry and academia to explore options in continuous
manufacturing, and has emphasized that there are no regulatory hurdles though there may be a
lack of experience [64]. A regularly cited benefit of continuous manufacture is its decreased
dependence on the human operator. This may not only reduce operating costs, but also reduce
human error and losses incurred because of it. Accordingly, this automation may increase the
quality of products, which is essential in the world of pharmaceutical manufacturing, where most
losses and production setbacks are the results of failed quality checks. It has also been
hypothesized that continuous manufacturing can reduce capital costs, as smaller equipment is
needed for the same production targets, and also reduce equipment idle time (associated with
batch processes). While it has been proven that continuous manufacturing can be implemented to
produce high-quality small molecule drugs, the hypothesis that it also reduces capital and
operating costs have not been proven. This report seeks to compare the cost of designing a new
manufacturing facility from the ground up for both a batch and continuous manufacturing
facility, such that pharmaceutical companies deciding which route to pursue for the production of
a new drug can assess the economics of each option.
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Section 10: Preliminary Process Synthesis
Section 10.1 Granulation
Granulation is the process of particle enlargement in which powder particles are
agglomerated while retaining the integrity of the original particles. It transforms fine powders
into free-flowing dust-free granules which are easily compressed [53]. Granules are produced to
enhance the uniformity of the API in the final product, to increase the density of the blend so that
it occupies less volume per unit weight, to facilitate metering or volumetric dispensing, to reduce
dust production, and to improve the appearance of the product [53].
There are several options for batch granulation. The two major categories of granulation
are wet and dry granulation. Wet granulation involves the addition of a liquid binder solution for
granulation, while dry granulation does not. Wet granulation is preferred so long as the API is
not largely heat or moisture sensitive [32]. Most generic small molecule tablets are produced
using wet granulation, and it is assumed that the API is not heat or moisture sensitive, so wet
granulation was chosen for this process. Within the category of wet granulation, there are several
more options—fluid bed spray granulation and integrated high shear granulation. The main
difference between the two types is the properties of the granules produced. It is found that highshear granules are denser, while fluid bed granules have a higher porosity and less spherical
shape. It has also been reported that fluid bed granulators have a narrower particle size
distribution [37]. It was decided that fluid bed granulation would be an appropriate choice for the
granulation of a typical, small molecule drug product.
There are several types of fluid bed granulators available for pharmaceutical applications,
including top spray, tangential spray, and bottom spray fluid granulators. Top-spray fluid bed
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granulation is the most well-established in the pharmaceutical industry and was chosen for this
process [26].
To lower capital costs, a single vessel capable of performing both fluid bed drying, and
fluid bed granulation was chosen. Glatt is one of the industrial leaders in the production of fluid
bed granulators and dryers, and the fluid bed granulator and dryer used in the batch process was
modeled after their GPCG PRO 30 Fluid Bed Dryer Granulator. Cost estimates were obtained
from a Glatt representative, and the brochure for this piece of the equipment is included in the
appendix (Section 25.10.1).
Continuous pharmaceutical production is a relatively new field, and thus there are less
options for continuous granulation equipment. The most widely cited equipment type used for
continuous granulation in the literature is a continuous twin-screw granulator [27]. The twinscrew granulator used in this process was modeled after the Thermo-Fisher Scientific Pharma 25
Twin Screw Extruder. This model was found to be compatible with the selected continuous
fluid-bed dryer, and capable of handling the required throughput for the system. A brochure for
this piece of equipment is included in the appendix (Section 25.10.3).
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Figure 10.1.1: Glatt GPCG Pro Fluid Bed Granulator and
Dryer vessel (B) and schematic showing trop-spray wet
granulation technique. [58]

Section 10.2 Drying
Fluid bed dryers are the most suitable for drying of granular crystalline, coarse, or similar
material in pharmaceuticals, fine chemicals, dyes, food and allied products [44]. They are widely
used across the pharmaceutical industry for the drying of wet granules, and therefore this type of
dryer is used for both the batch and continuous processes. Fluid bed dryers are designed to
introduce a hot air stream through the base of the vessel to fluidize its contents. The particles
each get fully surrounded by hot air, resulting in efficient heat transfer. The only other
reasonable option for the drying of pharmaceutical granules is a tray dryer, however fluid bed
dryers occupy less floor space and can dry the material in less time [44].
The granulator described in Section 10.1 for the batch process functions as fluid bed
dryer as well as a fluid bed granulator, and an additional piece of equipment is not needed. The
continuous fluid bed dryer used in this process is modeled after the one used in the MODCOS

34

continuous production line manufactured by Glatt, and equipment brochures are included in the
appendix (Section 25.10.2). The vessel is essentially a smaller model of the GPCG fluid bed
dryer used in the batch process, but runs in continuous mode, and is compatible with the
continuous twin screw granulator.

Figure 10.2.1: Lab scale model of Glatt MODCOS continuous
production line. This line incorporates the Glatt continuous fluid
bed dryer and Thermo-Fisher Scientific Pharma 25 Twin Screw
Extruder

Section 10.3 Milling
Milling is a semi-continuous process that improves drug dissolution and solubility [31]
by making the particle size distribution more uniform. It also increases the surface area of the
particles by breaking down particle agglomerates that may have formed after granulation and
drying.
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The primary purpose for milling in this process is delumping and particle
deagglomeration. The mill must be run at the least possible aggressive conditions to reduce fines
generation. Fines are extremely fine particles produced when the mill is run at aggressive
conditions. Accumulation of these particles is dangerous for the operator and can cause dust
explosions. The Quadro FlexSift S20 was selected for both the batch and continuous
manufacturing processes as it can gently delump the particles without particle size reduction and
with very low fines generation. This equipment also improves security screening, as it can
remove any impurities present in the material.
The Quadro FlexSift S20 is also flexible. If milling at more aggressive conditions is
required, the FlexSift S20 head shown in Figure 10.3.1 can be replaced with a Comil U20 head,
which improves particle size distribution and causes particle size reduction. Further details about
the equipment can be found in Section 15.1.3. Other equipment, such as the Hanningfield UniMill and Kek belt drive cone mill, was considered but ultimately rejected because it did not
provide flexibility to change milling conditions depending on material properties and was more
expensive than the FlexSift S20. A brochure for the Quadro FlexSift S20 is included in the
appendix (Section 25.10.5).
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Figure 10.3.1: Quadro FlexSift S20 with motor and control panel

Section 10.4 Blending
Blending is the mixing of API and excipients to obtain a homogenized product. A
uniform blend of API and excipients must be produced, and segregation of the mixture post
blending must be prevented. Segregation is the separation of particles in the blend due to
differences in properties such as particle size and density. It is dangerous because it can cause
tablets from the same batch to have different API and excipient compositions, which can alter the
tablets’ safety and efficacy [2]. The risk for segregation is low in these manufacturing processes
as the output from the blender goes directly to the tablet press, without extra handling steps, and
because the blend has been optimized by an R&D team such that the particles have just enough
cohesivity to prevent segregation but are also sufficiently free flowing such that there are no
interruptions to the process. Therefore, blending consists of producing an adequate blend,
maintaining the blend through subsequent handling steps, and verifying that the blend is properly
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homogenized [2]. Blending validation will be optimized by the blending R&D team and is out of
scope for this report.
There are three mechanisms by which blending occurs—diffusion, convection, and shear.
Diffusion is the random motion of particles, leading to the particles being redistributed.
Convection is the movement of large groups of adjacent particles within the blend in the
direction of flow. Shear helps in breaking particle agglomerates by facilitating the movement of
one layer of material over another when both layers have different velocities. The degree to
which these mechanisms contribute to producing a homogenized blend depends on the type of
blender used and on flow properties [2].
For the batch process, based on a recommendation from our project author, the bin
blender was selected. Other types of blenders include ribbon blenders and double-cone blenders,
to name a few. The bin blender was chosen because it houses the blending bin and the drive
mechanism separately, which increases the efficiency of the equipment because the bin can be
charged, discharged, and cleaned separately. The bin containing the API and excipients rotates
with the help of the drive mechanism to homogenize the mixture. LB Bohle was selected as the
equipment manufacturer due to its stellar reputation in the pharmaceutical industry. Some
headspace is needed in the bin blender to allow for the expansion of the material due to the
motion of the blender. To accommodate the large batch size of 2000 kg with a bulk density of
0.5 kg/L, an LB Bohle container blender (PM-6000) as shown in Figure 10.4.1 with a volume of
6000 L and fill level of 20% to 85% was selected. Other vendors selling container blenders, such
as GEA, were considered but the equipment sold by these vendors was unable to accommodate
the large volume required for the batch. The value of fill level used in calculations in Section
14.1.4 was 85%. Special containment flaps can be added to the blending container for dust-free
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operations. A brochure for the LB Bohle container blender (PM-6000) is included in the
appendix (Section 25.10.6).
For the continuous process, based on the recommendation of our project author, the
continuous blender was selected. Most continuous blenders are tubular in design with a shaft
fitted axially in the center of the blender. The shaft has blades all over its surface for mixing the
material and helping it move through the blender. Gericke was selected as the equipment
manufacturer due to its stellar reputation in the pharmaceutical industry. The Gericke continuous
blender (GCM-450) in Figure 10.4.2 was used for the process as it supported the required
throughput for the process. An alternative under consideration was the Amixon continuous mixer
(AMK-3000), but it was rejected because of its large size and large space requirements.
Additionally, the power requirement of 22-30 kW for the AMK-3000 was much larger than that
for the GCM-450 (0.37 kW). Therefore, the GCM-450 was chosen due to its modular design and
lower power requirements. A brochure for the Gericke continuous blender (GCM-450) is
included in the appendix (Section 25.10.7).
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Figure 10.4.1: LB Bohle PM-6000 container blender with
discharge vessel to collect output

Figure 10.4.2: Gericke continuous blender (GCM-450)
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Section 10.5 Compression
During compression, the blend of powder is run through a tablet press to be compressed
into tablets. The tablet press is usually the point of the process where problems are first
recognized as mechanical changes to raw material properties can result in variations from batch
to batch [28]. There are two types of tablet presses—single punch and rotary tablet presses. The
single punch is the simplest machine for tablet manufacturing. The rotary press is the more
suitable machine for the scale of manufacturing being studied in this project. One of the benefits
of the rotary tablet press is that it has high productivity with minimal labor. A rotary tablet press
can achieve the output that is required for both the batch and continuous process. Additionally,
the powder filled cavity can be managed automatically by the moving feeder. With the rotary
tablet press, waste of valuable formulation can be decreased, and the machine allows
independent control of weight and hardness of the tablets [46].
GEA’s MODUL P tablet press can be used for both designs and has been selected for its
associated benefits. This tablet press is designed based on the exchangeable compression module
[22]. All the product contact parts are contained in an isolated dust-tight module that can be
removed in a contained manner, leaving the machine powder free. This machine has fast product
changeover, improves productivity, provides a safe working environment and allows for
individual control of tablet hardness [22]. Figure 10.5.1 shows GEA’s MODUL™ P Tablet
Press.
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Figure 10.5.1: GEA’s MODUL™ P Tablet
Press
Section 10.6 Coating
There are three types of tablet coaters—standard coating pan, perforated pan, and
fluidized bed/air suspension system. The standard coating pan is a circular metal pan that rotates
with an electric motor. A perforated pan is a partial or fully perforated drum that rotates on a
horizontal axis and is enclosed in sealing housing. A fluidized bed/air suspension system has a
chamber that is usually a vertical cylinder where fluidization of the pellets is achieved by a
column of air flowing upwards from the bottom center of the cylinder. The tablets in the center
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move upwards in the air flow and fall outwards and downwards to the chamber wall, re-entering
the air stream from the bottom part of the column. Spray nozzles located at the bottom and the
top of the chamber are used to introduce the coating solution. A fully perforated pan is used for
both the batch and continuous process because they show increasingly versatile coating
capability, and they are reported to be more efficient than other methods in drying the tablet bed
[30].
There are several different perforated pans that could be used for the processes.
Ultimately, it was decided that tablet coaters from Thomas Engineering would be used for both
processes because the vendors provided the most information compared to the other vendors who
were contacted. Additionally, Thomas Engineering is a leader in the in the tablet coating
industry.
For the batch process, Accela-Cota® tablet coating systems from Thomas Engineering
are used. This machine features a fully perforated coating drum the revolutionized the coating
manufacturing process when it was introduced in 1969. This machine continues to set standards
for tablet coating with unrestricted air flow, thermodynamic efficiency, and flexibility [55].
Some additional benefits of this machine include reduced installation space, a highly accurate
flowmeter for solution flow control, coating chamber geometry that is optimized for effective
cleaning and drainage and a range of wash-in-place (WIP) options [55]. Figure 10.6.1 shows
Thomas Engineering’s Accela-Cota® tablet coating system. A brochure for this equipment is
included in the appendix (Section 25.10.8).
For the continuous process, the Thomas Flex CTC® Continuous Tablet Coater from
Thomas Engineering is used. This machine extends the film coating technology from the typical
batch process to a fast and efficient continuous process. The Flex CTC® achieves the same high
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performance demonstrated in the batch coaters but in much less time. Additionally, this machine
offers the industry’s leading product volume and a complete system automation with the
industry-leading Thomas Compu-Coat® control software that provides total process control,
repeatability, and validation documentation [16]. Figure 10.6.2 shows Thomas Engineering’s
Flex CTC® Continuous Tablet Coater. A brochure for this equipment is included in the appendix
(Section 25.10.10).

Figure 10.6.1: Thomas Engineering’s Accela-Cota® tablet coating systems
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Figure 10.6.2: Thomas Engineering’s Flex CTC® Continuous Tablet Coater

45

Section 11: Assembly of
Database

46

Section 11: Assembly of Database
The processes studied in this report involve solids handling, and do not involve any
chemical reactions. Properties of the API involved in this process were not defined, and therefore
the API and excipients were modeled to have the thermophysical properties (heat capacity,
density, etc.) of water. Small molecule drug composition was modeled after that of
acetaminophen. Each tablet was modeled to have 325 mg of active ingredient and a 50% drug
load, resulting in a total drug weight of 650 mg. To meet the production goal of one billion
tablets per year, this requires that 1970 kg of tablets be produced daily. The batch size was
rounded to 2,000 kg to simplify calculations. The bulk density of the API and excipients was
taken to be 0.5 g/mL.
While several different types of excipients are used in the formulation of a small
molecule drug product, differentiation of the type and therefore thermophysical properties of
each type are beyond the scope of this project. Thus, each type is simply referred to as
“excipient” and modeled with the properties of water. Different amounts of excipients enter the
process at different times through various unit operations. All the API and 52% of excipients (by
weight) enter the process during initial blending, 4% of excipients enter as part of the binder
solution, 36% are added during the second blending step, and the final 8% enters as coating. This
breakdown is represented in Table 11.1. The price of all the excipients is taken to be $0.05/kg.
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Initial Blending
Granulation
Drying
Milling
Second Blending
Compression
Coating

Table 11.1. Excipient Addition Schedule
Percent API Added
Percent Excipient Added
100
52
0
4
0
0
0
0
0
36
0
0
0
8
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Section 12: Process Flow Diagrams and Material Balances
Block flow and process flow diagrams for both the batch and continuous processes are
presented in Figures 12.1.1-12.2.2. The block flow diagrams show a broad overview of each
process and emphasizes the important flow rates or batch sizes, while the process flow diagrams
show greater detail and includes smaller-scale process machinery and heat exchangers. Tables
12.1 (batch) and 12.2 (continuous) provide detailed property descriptions of the streams reflected
in Figures 12.1.2 and 12.2.2. Granulation and drying occur in the same vessel for the batch
process, and separate vessels for the continuous process, as is reflected in the diagrams.
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Section 12.1 Process Flow Diagrams for the Batch Process

Blending

Blending

Coating

Figure 12.1.1. Batch Process Block Flow Diagram

Granulation
and Drying
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Figure 12.1.2. Process flow diagram for the batch process
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Figure 12.2.1. Block flow diagram for the continuous process.

Section 12.2 Process Flow Diagrams for the Continuous Process
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Figure 12.2.2. Process flow diagram for the continuous process.
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Section 13: Process Descriptions
Both processes were designed using the same unit operations. However, the equipment
and process specifications differ for each and are described in detail below.
Section 13.1 Batch Process
The batch manufacturing process is designed in such a way that solids flow is handled in
a gravity driven manner, using split butterfly valves. Figure 12.1.1 shows the block flow diagram
for this process, where the material flows through all the unit operations in six different vessels.
Initial weighing, dispensing, and blending will occur on the top (fourth) floor of the building and
will last for two hours. Next, the solids drop into the granulation and drying vessel on the third
floor, where the materials are granulated for three hours and dried for six. After drying, the
material flows to the mill on the second floor, where it will be milled for four hours. After
milling, a second blending operation lasting two hours occurs on floor one before the material
flows down to the ground floor for compression and coating. Compression is the bottleneck
operation, and lasts approximately 21 hours, after which the material is transferred in mini bags
using a forklift to the coater on the same floor. After six hours in the tablet coater, the process is
complete. The detailed schedule for this process can be seen in Figures 13.1.1 and 13.1.2,
representing the equipment occupancy and Gantt charts, respectively. It takes approximately 30
minutes to load and unload each vessel, and this time is accounted for in the schedule. The
equipment is cleaned using clean-in-place (CIP) followed by steam-in-place (SIP) operations
after every eight batches, and the timing of these cleaning operations is shown in the Gantt chart.
The total recipe batch time is about 47 hours, but the cycle time is only 24 hours, allowing for
the production of one 2,000 kg batch daily to meet the production goal of 330 batches per year.
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Figure 13.1.1. Equipment occupancy chart for two full batches. Process batch time is 46.5 hours,
while the cycle time is 24 hours. The equipment is cleaned prior to use after every eight batches
using CIP followed by SIP.

Figure 13.1.2. Gantt chart for the batch process, showing the details of each unit operation.
Times for cleaning, loading, and unloading equipment are all accounted for.
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13.1.1 Top-Spray Fluid Bed Granulation
Granulation is the process of particle size enlargement through the agglomeration of
powder particles. Granulation transforms the size, shape, and density of powders to improve their
physicochemical properties and handling. This process transforms fine powders into free-flowing
dust-free granules which are easily compressed further down the line. It also enhances uniformity
of the API in the final product, as shown in Figure 13.1.3 [53].

Figure 13.1.3. Granulation of powder changes the size, shape, and density of
powders, resulting in uniform granules with good flowability which are more easily
compressed.
There are several methods through which granulation can be performed, and they fall into
two main categories: dry and wet granulation. During dry granulation, powder particles are
agglomerated under high pressure, whereas during wet granulation, dry powders are
agglomerated through implementation of a granulating fluid. The granulating fluid is made up of
binders, or excipients that function to hold the granules together, and a volatile solvent, usually
water. Binder choice depends on the properties of the API and desired granule qualities, but they
usually come in the form of natural or synthetic polymers. Pregelatinized starch is used widely
throughout the pharmaceutical industry and is therefore chosen as a model binder for this process
[10]. For the batch process, fluid bed granulation will be implemented for this unit operation as it
is well established in the pharmaceutical industry and can be performed in the same vessel as
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drying, resulting in lower capital costs. This vessel is represented by GR-1(B)/DR-1(B) in Figure
12.1.2. The process begins with charging of the solids in stream S-3(B) into the vessel, followed
by bed fluidization with hot air. Before reaching the vessel, the air is passed through a blower,
BL-1(B), and a heat exchanger, HX-1(B), to heat it to the desired temperature. After the granules
have been fluidized, the binder solution is pumped into the vessel through PM-1(B) from the top
to achieve top-spray wet granulation. The details of this equipment can be found in section
15.1.1. Granulation is run for three hours. There are several important design specifications
associated with this process. Important process variables include fluidizing air flow rate,
fluidizing air temperature, fluidizing air humidity, and liquid to solid (L/S) ratio. The L/S ratio is
defined as the ratio of liquid binder solution flow rate to solid blend flow rate. There have been
many experiments conducted to optimize these variables, and values were chosen based on
comparison to similar processes reported in the literature, as well as heat transfer and humidity
calculations, which are included in Section 25.3.1 [17]. Fluidizing air will be introduced to the
system through stream S-11(B) at a volumetric flow rate of 2,800 m3/h at 55°C, and an absolute
humidity of 10 (g water/kg air). Binder solution is added at a 20% w/w water to solids ratio,
resulting in the addition of 344 kg of an 11% binder solution. Granulation will be performed
under saturated conditions, and exhaust air will leave the vessel at a temperature of 25ºC and a
saturated absolute humidity of 19.4 g water/kg air, resulting in evaporation of 62 kg of water
during this process. The remaining 242 kg of water is evaporated during drying. After three
hours, granulation is finished, and drying begins in the same vessel. The properties of the air
streams associated with granulation are tabulated below. While there is a pressure increase
through the blower, it is small enough to assume that the air physical properties are not affected.
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Table 13.1.1. Properties of Air Stream for Fluid Bed Granulation
Air Stream

Temperature
(ºC)

Pressure
(atm)

Volumetric Flow
(m3/h)

S-9(B)

25

1.0

2,500

Absolute
Humidity
(gH2O/kgair)
10.0

S-10(B)

25

1.2

2,500

10.0

S-11(B) (vessel inlet)

55

1.2

2,800

10.0

S-14(B) (exhaust)

25

1.0

2,500

19.4

13.1.2 Fluid Bed Drying
After granulation, the wet granules must be fully dried. This will be accomplished
through fluid bed drying, which has been extensively used in the pharmaceutical industry. The
same blower described in Section 13.1.1, BL-1(B), increases the velocity of the air before it is
sent to the heat exchanger, HX-1(B), through stream S-10(B), where it is brought to the desired
temperature. The hot air is introduced through the bottom of the vessel in stream S-11(B) at a
high enough velocity to fluidize the wet particles. The wet solids are suspended in the stream,
and heat transfer occurs through direct contact of the hot air and wet solids, evaporating all the
water and leaving behind the binder. The inlet air flow rate, temperature, and humidity were
chosen to meet a desired drying time of six hours, and to agree with optimization variables found
in the literature [54]. The heat transfer equations used to determine these parameters are detailed
further in sections 14.1.2 and 25.3.2. An inlet air flow rate of 5,200 m3/h at 75°C was determined
on the assumption of 80% heat transfer efficiency. The air enters at an absolute humidity of 10 g
water/kg air and exits at 40°C and an absolute humidity of 21.4 g water/kg air, which is below
the saturation point at this temperature. During drying, the granules are brought to an operation
temperature of 40°C. Before the granules leave the system, the heat exchanger is turned off and
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ambient air is run through the system long enough for the granules to cool back down to 25°C
before they are transferred to the mill. Properties of the air streams involved in this process are
tabulated in Table 13.1.2.
Table 13.1.2. Properties of Air Stream for Fluid Bed Drying
Air Stream

Temperature
(ºC)

Pressure
(atm)

Volumetric Flow
(m3/h)

S-9(B)

25

1.0

4,400

Absolute
Humidity
(gH2O/kgair)
10.0

S-10(B)

25

1.2

5,200

10.0

S-11(B) (vessel inlet)

75

1.2

4,400

10.0

S-14(B) (exhaust)

40

1.0

4,600

18.7

13.1.3 Milling
After granulation and drying, particle agglomerates may have been formed, and these
need to be broken down. The output from the granulator is introduced to the milling chamber
with a screen around it. The rotation of the milling chamber forces the particles to go through the
screen due to centrifugal acceleration [2]. The particles discharged from the screen are collected
and are transported to the blender. Any impurities in the input material are left behind in the
milling chamber. The milling for this manufacturing process primarily serves the purpose of
delumping particle agglomerates, and so the generation of fines due to milling is negligible.
Some process parameters for milling include the mill speed and screen size [2]. The mill
is run at the least aggressive conditions possible, and so the mill speed is chosen to be 700 RPM
to reduce the generation of fines. The screen consists of round holes with a diameter of 1.9 mm.
These process parameters can be optimized by a process R&D team to further reduce the
generation of fines.
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For this process, the Quadro FlexSift S20 (Figure 13.1.4) as selected, as discussed in
Section 10.3. Further details on the equipment are provided in Section 15.1.3.

Figure 13.1.4. Schematic of Quadro FlexSift S20

13.1.4 Bin Blender
Blending occurs twice in the batch process—once before granulation, and once after
milling. The blending step before granulation is known as pre-blending, and it is necessary for
achieving a uniform distribution of API and excipients in the powder mixture [53] prior to
granulation. 1,000 kg of API and 520 kg of excipients are added to the pre-blender. As seen in
Figure 12.1.1, excipients are added in both pre-blending and blending unit operations. 52% of the
excipients are added during pre-blending, and 36% are added during blending. Most excipients,
except lubricants, can be added during either pre-blending or blending. Lubricants are added
during blending (after milling) as they facilitate tablet compression by preventing the tablets
from adhering to the tablet punches in the tablet press.
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Some process parameters for blending include the loading order of materials into the
blender, blender rotation speed, and fill level [2]. The amount of excipients added to the blender
is low as compared to the other input to the blender from the mill. Thus, if all excipients are
added first, then the blend may not be properly homogenized because the excipients could lie in
one part of the blender and not spread into the mixture. Therefore, the input to the blender from
the mill (mill output) and the input excipients can be added in two ways. Either the excipients are
all added after the material from the mill is sitting in the blender, or both inputs are added in
layers—first, a layer of the mill output, then a layer of excipients, followed by another layer of
the mill output, and so on. Using either of these methods to load the blender ensures that the API
and excipients are mixed uniformly [5]. As for blender rotation speed, as the amount of material
to be blended increases, the required rotation speed decreases [8]. Lastly, the fill level of the
blender is important as some headspace is required to accommodate the expansion of the
material due to motion of the blender. A fill level of 65-75% is typical for bin blenders [2]. As
mentioned in Section 10.4, the LB Bohle container blender (PM-6000) can have a working
volume of 20-85%. Therefore, to accommodate the large batch size in a reasonably sized blender
for the batch process under consideration, a fill level of 85% is used in calculations in Section
14.1.4.
For the batch manufacturing process, a bin blender is used. A bin blender (Figure 13.1.5)
consists of a blending container that is rotated with the help of a drive mechanism. The rotation
of the blender causes the particles to move by convection and diffusion. Bin blenders are low
shear blenders as the blending mechanism is gentle and the shear forces are low. There are some
shear forces due to slip plane formation between the walls of the blender and layers in the blend,
but these shear forces are small as compared to those due to other types of blenders [2]. Bin
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blenders are used for this batch manufacturing process as blending in this case is primarily
needed for lubricating the formulation. An advantage of bin blenders is that the blending bin is
separate from the drive mechanism, which increases the efficiency of the equipment because the
bin can be charged, discharged, and cleaned separately. Therefore, bin blenders help in reducing
the time needed for cleaning. More information about the bin blender is in Section 15.1.4.

Figure 13.1.5 Schematic showing how a bin blender works.

13.1.5 Rotary Tablet Press
The feeder feeds the powder blend of API and excipients from the blender into the dies of
the rotary press. In the rotary tablet press, there are several tooling stations that rotate to
compress the powder blend into tablets. Figure 13.1.6 shows how the rotary tablet press operates.
The compaction force is exerted on the fill cam by both the upper and lower punches,
compressing the powder blend in the middle-accordion of the tablet press. The rotary tablet press
capacity is determined by the rotation speed of the turret and the number of stations the tablet
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press has. The pre-compression roller gives the granules the initial compression force and gets
rid of excess air that is trapped in the die. The main compression roller applies the final
compression force that formulates the tablets. The ejection cam guides the lower punch upwards
and ejects the tablets from the die cavity [46]. The tablets are then discharged from the tablet
press. The tablet press parameters are compression force (pre-compression force and main
compression force), turret speed, and feeder speed [39]. Compression is the bottleneck operation
for both processes. For the batch process, the tablet press runs for 21 hours to produce the
required output of 144,300 tablets/hr.

Figure 13.1.6. Schematic of how a rotary tablet press works. In this process, the powder
blend will be placed in the dies and compressed using the pre-compression roll and main
compression roll before being ejected [12].
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13.1.6 Batch Fully Perforated Pan
During coating, specific functionalities of the tablet are enhanced. These functionalities
include concealing of any bitter tastes, creation of smooth coverings to facilitate swallowing,
protection of the pill from damage due to external forces, and branding. There are different types
of tablet coating solutions. Sugar coating obscures bitter taste and is mainly used for drugs for
children. Film coated tablets are stable and strong and are used for tablet branding. Gelatin
coated tablets are protein rich. Enteric coated tablets help to deliver the tablet to intestines
without causing damage to the consumer. Other types of coating include electrostatic coating,
dip coating, and rotary die coating. Since this is a generic design, this report does not specify the
type of coating that the tablet has and assumes that tablet has some film coating [11]. For the
analysis, the coating solution is assumed to contain mostly water and some carbohydrates.
A fully perforated pan will be used for the batch process. The fully perforated pan rotates
on its horizontal axis and the whole system is enclosed in sealed housing. The tablets are placed
in the tablet bed and are sprayed with coating solution using a spraying arm as shown in Figure
13.1.7. The drying air is passed through the tablet bed and is released through the perforations in
the drum. The fully perforated pan shows increasingly versatile coating capability and is more
efficient than other methods of drying [30]. The uncoated tablets are placed in the fully
perforated pan and a coating solution is pumped into the fully perforated pan using the spraying
arm as shown in Figure 13.1.7. The coating solution (790 kg/batch) is made up of a solution of
90% water and 10% organic coating. For this process, the process airflow for drying the coating
on the tablet was determined to be 17,900 m3/h and this air is heated to 75°C by the heat
exchanger before entering the tablet coater to dry the coating. Properties of the air stream
entering this process can be found in Table 13.1.3. The calculations for how the air flow was
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determined can be found in Sections 25.3.1 and 25.3.2. This coating process will take 6 hours
including drying. The evaporated water from the coating solution and the drying air is removed
from the perforated pan through the exhaust. Before the tablets are removed from the system, the
heat exchanger is turned off and ambient air is run through the system long enough for the tablets
to cool down to 25°C from 45°C.
Table 13.1.3. Properties of Air Stream Entering the Batch Coater
Air Stream

Temperature
(ºC)

Pressure
(atm)

Volumetric Flow
(m3/h)

S-16(B)

25

1.0

15,300

Absolute
Humidity
(gH2O/kgair)
10.0

S-17(B)

25

1.2

15,300

10.0

S-18(B) (vessel inlet)

75

1.2

17,900

10.0

S-21(B) (exhaust)

45

1.0

16,300

18.1

Figure 13.1.7. Schematic of Fully Perforated drum
for a batch process. In this process, the tablets are
coated in the tablet with a coating solution using a
spraying arm and dried with air as the perforated
pan is rotates [57].
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Section 13.2 Continuous Process
The continuous manufacturing process is designed in such a way that solids flow is
handled in a horizontal manner, in a single floor facility. Figure 12.2.1 shows the block flow
diagram for this process, where the material flows through all the unit operations in seven
different vessels. Initial weighing, dispensing, and blending is the first step of the continuous
process. Next, the solids are conveyed to the granulator, followed by the drying vessel. After
drying, the material is conveyed into the mill. After milling, a second blending operation occurs,
before the material is conveyed into the tablet press and coater. After each unit operation, the
material is transferred to the next unit operation by using different types of conveying. The solid
materials in the process are conveyed pneumatically through a piping system throughout the
process until after the second blending (after milling). Screw conveying will be used to transfer
the blend to the tablet press from the second blending operation to prevent segregation of the
blend. Information about cleaning during the continuous process can be found in Section 20.4.
13.2.1 Continuous Twin Screw Granulation
While the chosen method is different, the same principles described in Section 13.1.1
apply for continuous granulation. For this process, a continuous twin-screw wet granulator
(TSWG) will be used. Increased interest in continuous manufacturing has turned manufacturers
in the pharmaceutical industry towards alternative methods for granulation, and twin-screw
granulation (TSG) has emerged as the most prevalent continuous option [3]. As opposed to topspray fluid bed granulation, which is used for the batch process, twin screw granulation reduces
labor and space, and can be operated at ambient temperatures. A schematic of this process is
shown in Figure 13.2.1 and corresponds to vessel GR-1(C) of Figure 12.2.2. Twin screw
granulators are comprised of mixing zones and kneading zones. After initial blending, powder is
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conveyed to the TSWG and introduced through a feeder. It is first brought to the mixing zone,
where the powder is mixed at room temperature with a binder solution. The kneading zone
consists of two co-rotating screws composed of screw elements of desired geometry enclosed in
a barrel. Parameters for this process include screw speed, liquid to solid (L/S) ratio, screw
configuration, and barrel temperature. The L/S ratio is defined as the ratio of liquid binder
solution flow rate to solid blend flow rate. Because this process focuses on the design of a
versatile process, specifications of screw speed and geometry are ignored as they can be varied
using the designed equipment without affecting economic and safety evaluation. Through
analysis of figure 12.2.2, powder is introduced to the continuous granulator at a throughput of 62
kg/h through stream S-3(C), and 10 kg/h of a 17% binder solution is pumped into the granulator
through stream S-11(C) by PM-1(C) and added to the powder resulting in a 13% L/S ratio. The
process is run at room temperature to eliminate any extra costs of heating, and the wet granules
are conveyed to the continuous fluid-bed dryer after the process is complete.

Figure 13.2.1. Schematic of a twin-screw wet granulator. Powder is
introduced after initial blending and conveyed first through the mixing zone
where the binder liquid is introduced and then through the kneading zone
where agglomerates are formed [49].

72

13.2.2 Continuous Fluid Bed Drying
Continuous fluid bed drying follows the same principles as the fluid bed dryer described
in section 13.1.2, however it is designed as a horizontal vessel where the wet granules are dried
as they continuously flow through the vessel, as is shown in figure 13.2.2. Differing from the
schematic in Figure 13.2.2, the wet granules are conveyed into the vessel from the TSWG and
fluidized using hot air flow up through the bottom of the vessel. Heat transfer calculations were
used to determine inlet air flow rate, temperature, and humidity, as described in section 13.1.2.
Following the process flow diagram in Figure 12.2.2, the blower, BL-1(C) increases the velocity
of the air in stream S-12(C) before it is sent to the heat exchanger, HX-1(C), in stream S-13(C),
and heated to a temperature of 75°C. The air enters the dryer through S-14(C) at a volumetric
flow rate of 1150 m3/h at an absolute humidity of 10 g water/kg air to achieve evaporation of 8
kg/h of water, resulting in total drying. The air enters at an absolute humidity of 12.5 g water/kg
air and exits at 40°C at 17.0 g water/kg air. The dry granules are heated to 40°C during the
process but exit at 25°C after HX-1(C) is turned off and the granules are cooled using ambient
air. Properties of the air streams involved in this process are tabulated below.
Table 13.2.1. Properties of Air Stream for Continuous Bed Drying
Air Stream

Temperature
(ºC)

Pressure
(atm)

Volumetric Flow
(m3/h)

S-12(C)

25

1.0

1,040

Absolute
Humidity
(gH2O/kgair)
10.0

S-13(C)

25

1.1

1,040

10.0

S-14(C) (vessel inlet)

75

1.1

1,150

10.0

S-15(C) (exhaust)

40

1.0

1,100

17.0
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Figure 13.2.2. Schematic of the continuous fluid bed dryer. In our process,
material will be conveyed directly from the TSWG into the fluid bed dryer,
where it flows horizontally and is fluidized by the inlet hot air, and dried using
the heat input due to the air [21].
13.2.3 Milling
The same mill is used for the continuous manufacturing process. The output from the
dryer is pneumatically conveyed to the mill. It should be noted that the drive motor value for the
mill used for the continuous process was lower than that for the batch process due to lower
throughput in the continuous process. The mill throughput for the continuous process was 64
kg/hr.
13.2.4 Continuous Blender
Like the batch process, blending occurs twice in the continuous process—once before
granulation, and once after milling. The blending step before granulation is known as preblending, and it is necessary for achieving a uniform distribution of API and excipients in the
powder mixture prior to granulation [53]. As seen in Figure 12.2.1, excipients are added in both
pre-blending and blending unit operations. 52% of the excipients are added during pre-blending,
and 36% are added during blending. Most excipients, except lubricants, can be added during
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either pre-blending or blending. Lubricants are added during blending (after milling) as they
facilitate tablet compression by preventing the tablets from adhering to the tablet punches in the
tablet press.
The output from the mill is pneumatically conveyed and fed to the continuous blender at
64 kg/hr. Excipients are fed continuously at 15 kg/hr to both the blender and pre-blender using
loss-in-weight feeders. API is introduced into the pre-blender at 41 kg/hr using a loss-in-weight
feeder. Continuous blenders (Figure 13.2.3) are cylindrical in shape with inputs being fed at one
end and outputs leaving at the other end. These blenders contain a motor-driven shaft fitted
axially in the center of the blender with many blades present along the shaft [38]. The rotation of
the shaft and blades mixes the inputs added to the blender and facilitates the motion of the
material through the blender. Using a continuous blender reduces the risk of segregation after
blending because the particles are blended continuously, and the blend will be transported to the
tablet press by a flexible screw conveyor. Also, continuous blenders are more compact, occupy
less space, and can be scaled up easily to obtain higher throughputs. The Gericke GCM-450
continuous blender was selected for this process. Further details on the equipment are provided
in Section 15.2.4.
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Figure 13.2.3. Schematic of a continuous blender.

13.2.5 Rotary Tablet Press
The same tablet press is used for the batch and continuous process. Section 13.1.5
describes how the tablet press operates. For the continuous process, the tablet press would
operate for 24 hours to produce 126,300 tablets/hr.

13.2.6 Continuous Fully Perforated Pan
For the continuous process, a fully perforated pan is used as in the batch process, but with
a shallow bed-depth that allows very high coating uniformity since the tablets are frequently
exposed to the spray cone. The continuous tablet coater operates with the same principles as the
batch tablet coater (Section 13.1.6). The tablets are fed into the tablet coater using a feeder at a
rate of 79 kg/h, where they are exposed to the coating solution with multiple spray nozzles as
shown in Figure 13.2.4. The coating solution is fed at a rate of 33 kg/h, and the solution is made
up of 90% water and 10% organic coating. An air supply of 6,800 m3/h is fed to a heat exchanger
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to be heated to 57°C and then fed to the perforated pan to dry the coating on the tablet. Properties
of the air flowing into the coater are reflected in Table 13.2.2. The calculations for how the air
flow was determined can be found in Sections 25.3.1 and 25.3.2. The evaporated water from the
coating solution and the drying air is removed from the perforated pan through the exhaust.
Before the tablets leave the system, the heat exchanger is turned off and ambient air is run
through the system to cool down the tablets to 25°C from 39°C.

Figure 13.2.4. Schematic of Fully Perforated drum for a continuous process. In this
process, the tablets are coated with a coating solution using multiple spraying arms and
dried with air [20].
Table 13.2.2. Properties of Air Stream Entering the Continuous Coater
Air Stream

Temperature
(ºC)

Pressure
(atm)

Volumetric Flow
(m3/h)

S-17(C)

25

1.0

6,200

Absolute
Humidity
(gH2O/kgair)
10.0

S-18(C)

25

1.2

6,200

10.0

S-19(C) (vessel inlet)

57

1.2

6,800

10.0

S-22(C) (exhaust)

39

1.0

6,400

15.1
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Section 14: Energy Balance and Utility Requirement
Section 14.1 Energy Balance and Utility Requirements for the Batch Process
14.1.1. Fluid Bed Granulator
Energy balances were performed on the overall fluid bed granulation process to
determine utility requirements. The work required to mechanically run the system was taken to
equal the motor power of each of the pieces of equipment. Heat analysis was performed to
determine the heat duty required from the inlet hot air. Granulation is run at ambient temperature
using airflow at 55°C, and the hot air is cooled down to 25°C through evaporative cooling during
the process. Granulation operates at saturated conditions, such that humid air enters the system
and leaves saturated, removing a fraction of the water. The amount of water evaporated during
granulation is thus determined by inlet air temperature, flow rate, and humidity, as shown in Eqn.
𝑇

𝑇

𝑓
14.1.1, where ∅𝑠𝑎𝑡
is the absolute humidity the saturated exhaust air, ∅𝑖 𝑖 is the inlet absolute

humidity (both measure in g water/kg air), and t is time. Heat transfer to the granules themselves
from the hot air is negligible. The airflow rates and temperatures for granulation were chosen
based on optimal values found in the literature [17] and confirmed by consultants. An inlet air
flow rate and temperature of 2,800 m3/h and 55°C were chosen for this process, and steam
requirements reflect the amount of steam needed to heat 2,800 m3/h of air to 55°C for three
hours. Steam requirement calculations were conducted using the equations included in Section
25.3.1 in the appendix. An important assumption made for these calculations is that the pressure
increase from the blower was small enough such that air properties are taken to be at ambient
conditions.
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𝑇

𝑚𝑤𝑎𝑡𝑒𝑟,𝑔𝑟𝑎𝑛 =

𝑇

𝑓
(∅𝑠𝑎𝑡
− ∅𝑖 𝑖 ) ∗ 𝑚̇𝑎𝑖𝑟 ∗ 𝑡 (14.4)

1000
(Eqn. 14.1.1)

Work requirements for the system include the energy required to power the blower, heat
exchanger and binder pump. The power requirements for the blower motor were modeled using
equations provided in Seider et al., 2017, and calculations can be shown in section 25.3.1. Due
to low binder volumetric flow rates, a peristaltic pump is used to introduce the binder fluid to the
system. An industrially available pump was selected, and utility requirements were obtained
from the equipment manual. Motor energy required for the fluid bed granulator was taken as
given from a representative at Glatt, who provided equipment cost and utility specifications for
the vessel, independent of the heat exchanger, blower, and pump systems. Heat exchanger
electricity requirements were determined through modeling in Aspen Plus, after all heat duty
calculations were performed. It is important to note that even though GR-1(B)/DR-1(B)
represents one piece of equipment, energy balances and utility calculations were performed for
the granulation and drying unit operations separately. The same applies for the use of BL-1(B)
and HX-1(B) during each of the operations separately.
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Table 14.1.1. Utilities for Batch Granulation
Equipment

Steam (kg/batch) Process Water
(kg/batch)

Motor Power
(kWh/batch)

Motor Power
Source

GR-1(B)

-

-

159

Glatt
Representative

HX-1(B)

105

-

156

Aspen

BL-1(B)

-

-

67

Seider, et al.

PM-1(B)

-

304

0

Equipment
Brochure

105

304

382

Total

Section 14.1.2 Fluid Bed Dryer
Fluid bed drying occurs in the same vessel as fluid bed granulation, and energy balances
and utility requirements were calculated accordingly. There is no pumping involved in the drying
process. Most of the heat provided to the system from the hot inlet air is used to evaporate the
water. The rest is used to heat the vessel and granules to the final operating temperature of 40ºC.
The equations used to model this system can be found in Section 25.3.2. Once the heat duty was
determined, it was possible to determine the mass and volumetric flow rate of air necessary for
operation. From this, the mass flow and volumetric flow of air was calculated, thus allowing for
calculation of steam utility requirements (see Section 25.3.2). It is assumed that the remainder of
the water was evaporated during drying. Drying occurs below saturation temperatures, and the
absolute humidity of the exhaust stream was calculated using equation 14.1.2.

𝑇

∅𝑓2 =

(𝑚𝑤𝑎𝑡𝑒𝑟,𝑡𝑜𝑡 − 𝑚𝑤𝑎𝑡𝑒𝑟,𝑔𝑟𝑎𝑛 )
𝑇
+ ∅𝑖 1
1000 ∗ 𝑚̇𝑎𝑖𝑟 ∗ 𝑡
Eqn. 14.1.2
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Blower motor power was determined, once again, using correlations reported in Seider et al.,
2017.
Table 14.1.2. Utilities for Batch Drying
Equipment

Steam (kg/batch)

Motor Power
(kWh/batch)

Motor Power Source

DR-1(B)

-

319

Glatt Representative

HX-1(B)

527

312

Aspen

BL-1(B)

-

245

Seider, et al.

527

876

Total

14.1.3 Milling
During milling, heat is produced due to the rotation of the milling chamber and
subsequent particle movement through the screen around the chamber. Energy balances were
used to calculate the amount of heat dissipated into the material during milling. The temperature
rise in the material if all the heat produced is absorbed by the material was calculated by using an
estimated value for the heat capacity of the material. Some of the heat produced could instead be
released into the surroundings. Based on a recommendation from the project author, the API and
excipients were assumed to have the properties of water. Also, the mill rotational speed was
assumed to be 700 RPM to prevent the generation of fines.
Based on a recommendation from our project author, any value of temperature rise below
10°C was considered acceptable. The value of this temperature rise was found to be
approximately 3°C, which was reasonable and would not adversely affect the quality of the
batch. The motor drive energy requirement was 3.73 kW, which was obtained for the Quadro
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FlexSift S20 from a Quadro sales representative. Detailed energy balance calculations are in the
Section 25.3.3.

Table 14.1.3. Utilities for the Batch Mill
Equipment

ML-1 (B)

Motor Power

Motor Power

(kWh/day)

Source

11.2

Quadro

14.1.4 Bin Blender
During blending, heat is produced due to the mixing of API and excipients. Energy
balances were used to calculate the amount of heat dissipated into the material during blending.
The temperature rise in the material if all the heat produced is absorbed by the material was
calculated by using an estimated value for the heat capacity of the material. Some of the heat
produced could instead be released into the surroundings. The API and excipients were assumed
to have the properties of water. Also, the blender rotational speed was assumed to be 5 RPM
because of the large batch size of 2000 kg. The larger the batch size, the lower the rotational
speed of the blender [8].
Based on a recommendation from our project author, any value of temperature rise below
10°C was considered acceptable. The values of the temperature rise for the pre-blender and
blender were found to be approximately 6.6°C and 5°C respectively. These values are reasonable
and would not adversely affect the quality of the batch. The motor drive energy requirements for
both blenders were 25.5 kW, obtained from an LB Bohle sales representative for an LB Bohle
container blender (PM-6000) with an overall capacity of 6000 L. The working volume of the
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blender is 5100 L, which is 85% of the overall capacity to account for the headspace needed in
the blender. Detailed energy balance calculations are in Section 25.3.4.

Table 14.1.4 Utilities for Batch Blender
Equipment
BL-1 (B)

Motor Power
(kWh/day)
17

Motor Power
Source
LB Bohle

BL-2 (B)

17

LB Bohle

14.1.5 Rotary Tablet Press
During compression, the compression force is one of the tablet press parameters. Work is
done on the powder to form a tablet by the compression force and heat is released by the system
during this process. Section 25.3.5 shows how the energy released by the system can be
calculated. The system is the powder in the die. Work is done on the system by the compression
force, and heat is released instead of absorbed by the system. To find the heat released by the
system, the heat capacity of the powder blend and temperature change is required. The API and
excipients are assumed to have the same heat capacity as water as described in Section 11.
Additionally, the work done by the compression force can be calculated from the compression
force and the turret speed. The properties of the tablet press that were used for these calculations
were obtained from a research article by Nayak et al [39]. The calculations for energy of the
tablet press can be found in Section 25.3.5. According to GEA, the consumption of the
MODUL™ P Tablet Press is 6 kW. The motor power for the tablet press was found using this
information from GEA and can be found Table 14.1.5.
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Table 14.1.5 Utilities for the Compressor for the
Batch Process
Equipment
Motor Power
Motor Power
(kWh/day)
Source
TP-1(B)
126
GEA

14.1.6 Batch Fully Perforated Pan
A thermodynamic model of the tablet coater allowed for determination of the heat loss of
the system by evaluating the enthalpy change of the processing air, and the enthalpy change of
the coating. For this calculation, it was assumed that 90% of the coating solution is water and
that all the water is evaporated during drying. These calculations can be found in Section 25.3.6.
The optimal airflow rate and temperature for coating were determined to be 17,900 m3/h and
75°C respectively, and steam requirements reflect the amount of steam needed to heat 17,900
m3/h of air to 75°C for 6 hours. These calculations are conducted similarly to the calculations for
the fluid bed granulator, detailed in Section 25.3.1.
Other energy input requirements to the system include the energy required to power the
heat exchanger, blowers, and to pump the coating solution into the tablet coater. The amount of
steam required for HX-2(B) was found the same way that it was found for the fluid bed
granulator as described in section 14.1.1. The power requirements for the blower motors were
modeled using equations provided in Seider et al., 2017. Similar to the fluid bed granulator, the
coating solution flow rates are low. Therefore, a peristaltic pump is used to introduce the coating
solution to the system. It was determined that the best pump for this operation is a
pharmaceutical pump, Verderflex Vantage 3000 P EZ Model. This pump’s specifications fall
within what is required for this process, as detailed in section 15, and the prescribed motor power
of this piece of equipment was used as the electricity requirement. According to a Thomas
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Engineering representative, the motor power required for the batch tablet coater is 5.6 kW. Table
14.1.6 summarizes the utility requirements for the batch tablet coater.

Table 14.1.6. Utilities for the Batch Tablet Coater
Equipment

PM-2(B)

-

-

0

HX-2(B)

1686

-

312

Motor Power
Source
Thomas
Engineering
Equipment
Brochure
Aspen

BL-2(B)

-

-

2756

Seider et al.

1686

711

2077

TC-1(B)

Total

Steam (kg/batch) Process water
(kg/batch)
711

Motor Power
(kWh/batch)
8.94

Section 14.2 Energy Balance and Utility Requirements for the Continuous Process
14.2.1. Continuous Twin Screw Granulation
In contrast to the fluid bed granulator used for the batch process, the twin screw
granulator does not require the use of fluidizing air or heat input. Thus, the only utility
requirements to the system are motor power and process water, and energy balances can
otherwise be ignored. Motor power requirements were obtained from a representative at ThermoFisher, and the same pump described in section 14.1.1 is used.
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Table 14.2.1. Utilities for the Continuous Granulator
Equipment

Process Water
(kg/day)

Motor Power
(kWh/day)

Motor Power Source

GR-1(C)

-

264

Thermo-Fisher
Representative

PM-1(C)

192

0

Equipment Brochure

Total

192

264

14.2.2 Continuous Fluid Bed Dryer
Calculations were performed using the same methods presented in section 14.1.2 for the
fluid bed dryer. Results from these calculations are tabulated below for the continuous process.
Energy required to heat the vessel is neglected in these calculations, as the continuous vessel will
be running continuously and therefore it is assumed that it will remain heated.

Table 14.2.2. Utilities for the Continuous Dryer
Equipment

Steam (kg/day)

Motor Power
(kWh/day)

Motor Power Source

DR-1(C)

-

288

Glatt Representative

HX-1(C)

264

1248

Aspen

BL-1(C)

-

113

Seider, et al.

690

1,649

Total
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14.2.3 Milling
Like milling in the batch process, energy balances for milling in the continuous process
were used to calculate the amount of heat dissipated into the material during milling. The
temperature rise in the material if all the heat produced is absorbed by the material was
calculated by using an estimated value for the heat capacity of the material. Some of the heat
produced could instead be released into the surroundings. The API and excipients were assumed
to have the properties of water. Also, the mill rotational speed was assumed to be 700 RPM to
prevent the generation of fines.
Based on a recommendation from our project author, any value of temperature rise below
10°C was considered acceptable. The value of this temperature rise was found to be
approximately 4°C, which was reasonable, and would not adversely affect the quality of the
material. The motor drive energy requirement was 3.73 kW, which was obtained for the Quadro
FlexSift S20 from a Quadro sales representative. However, the motor drive energy used in
calculations was 0.55 kW because a lower amount of energy is needed to mill the lower
throughput for the continuous process. The amount of material present at any given time in the
mill in the continuous process is lower than that in the batch process. Therefore, a lower amount
of energy is required to mill the lower amount of material. Detailed energy balance calculations
are in Section 25.3.3.

Table 14.2.3. Utilities for the Continuous Mill
Equipment
ML-1 (C)

Motor Power
(kWh/day)
13.2

Motor Power
Source
Quadro
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14.2.4 Continuous Blender
Similar to calculations for the batch blending process, energy balances were used to
calculate the amount of heat dissipated into the material during continuous blending. The
temperature rise in the material assuming that all the heat produced was absorbed by the material
was calculated by using an estimated value for the heat capacity of the material. However, it is
possible that some of the heat produced could instead be released into the surroundings. Also, the
blender rotational speed was assumed to be 25 RPM because the amount of material present in
the blender at any given time is smaller than that in the bin blender. A higher blender rotational
speed is needed to blend this smaller amount of material [8].
Based on a recommendation from our project author, a temperature rise below 10°C was
considered acceptable. The values of the temperature rise for the pre-blender and blender were
found to be approximately 2°C and 1.5°C respectively, which was reasonable, and would not
adversely affect the quality of the material. The motor drive energy requirement was 0.37 kW,
which was obtained for a Gericke GCM-450 continuous blender. Detailed energy balance
calculations are in Section 25.3.4.

Table 14.2.4. Utilities for the Continuous Blender
Equipment
BL-1 (C)

Motor Power
(kWh/day)
8.9

Motor Power
Source
Gericke

BL-2 (C)

8.9

Gericke
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14.2.5 Rotary Tablet Press
The same tablet press is used for both the batch and continuous process. The energy of
the tablet press was found the same way as described in section 14.1.5. For the continuous
process, calculations for the energy of the tablet press can be found in Section 25.3.5. The motor
power for the tablet press was also found from contacting a vendor from GEA and this is shown
in Table 14.2.5.

Table 14.2.5 Utilities for Compression for the
Continuous Process
Equipment
Motor Power
Motor Power
(kWh/day)
Source
TP-1
144
GEA

14.2.6 Continuous Fully Perforated Pan
A thermodynamic model similar to that used for the batch process (Section 14.1.6) can
also be used for the continuous process. The fully perforated continuous tablet coater would use
a process air volume of 6,800 m3/h and this can be used to determine the enthalpy change of the
processing air. Additionally, a publication from Thomas Engineering, shown in Section
25.10.11, provides information on the temperature of the inlet air, the temperature of the
exhausts and the product temperature. Information from the material balances from Section 12 is
used for these calculations. According to a Thomas Engineering representative, the motor power
required for the continuous tablet coater is 1.5 kW. Other utility calculations were calculated the
same ways as in Section 14.1.6. Detailed energy balance calculations are in Section 25.3.6.
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Table 14.2.6. Utilities for the Continuous Coater
Equipment
TC-1(C)

-

Process water
(kg/day)
29.7

PM-2(C)

-

-

0.3

Motor Power
Source
Thomas
Engineering
Seider et al.

HX-2(C)

113

-

1248

Aspen

BL-2(C)

-

-

4210

Seider et al.

113

29.7

5494

Total

Steam (kg/day)

Motor Power
(kWh/day)
35.8
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Section 15: Equipment List and Unit Descriptions
Section 15.1 Equipment List and Unit Descriptions for the Batch Process
15.1.1 Fluid Bed Granulator
Granulation and drying occur in one singular equipment vessel for this process. This was
designed with the intent to reduce capital costs. A highly regarded industrially used vessel from
Glatt, the GCCG Pro 30 Fluid Bed Dryer Granulator, was chosen as a model piece of equipment
for this process. Capital cost estimates for the entire system were obtained, however the heat
exchanger, pumps, and fans were designed independently to determine the utility requirements
accurately. Due to the small binder flow rate in the pump, a peristaltic pump is required and the
Venderflex Vantage 300 P EZ was chosen for this system due to its compatible specifications
and recorded use in pharmaceutical applications. The motor power required for the pump was
provided to be less than 1 kW and was taken to be negligible.
Unit

GR-1(B)/DR-1(B)

Type

Fluid Bed Granulator and Dryer

Material

Stainless Steel

Operating Temperature

25ºC /40ºC

Pressure

1 atm

Motor Power

53 kW

Specification Sheet

Section 16.1.1

Costing Data

Section 17.1
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Unit

HX-1(B)

Type

Counter-Current Heat Exchanger

Material

Stainless Steel

Pressure

1 atm

Motor Power

52 kW

Specification Sheet

Section 16.1.2

Design Calculations

Section 25.4.1

Unit

BL-1(B)

Type

Centrifugal Blower

Material

Stainless Steel

Motor Power

22/41 kW

Specification Sheet

Section 16.1.4

Design Calculations

Section 25.3.1

Unit

PM-1(B)

Type

Peristaltic Pump

Material

Stainless Steel

Pressure

1 atm

Motor Power

Negligible

Specification Sheet

16.1.3
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15.1.2 Fluid Bed Dryer
See Section 15.1.1.
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15.1.3 Mill
The primary purpose for milling in this process is delumping and particle
deagglomeration. The mill will be run at the least possible aggressive conditions to reduce fines
generation. The Quadro FlexSift S20 was selected as it can gently delump the particles without
particle size reduction and with very low fines generation. This equipment can also remove any
impurities present in the material.
This equipment consists of a powder processing head attached to an interface for
controlling the RPM at which the system is operating, and a motor for providing energy for the
rotation of the milling chamber. The powder processing head can be changed depending on the
milling conditions needed for the material. As discussed in Section 10.3, if more aggressive
milling is required, the FlexSift S20 head can be replaced by the Comil U20 head, which
improves particle size distributions. Therefore, this equipment is flexible and can handle the
milling needs for different types of materials. The motor power was obtained by speaking with a
Quadro sales representative.
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Unit

ML-1(B)

Type

Batch

Material

304 stainless steel, 316 stainless steel for
product contact parts

Operating temperature

25°C

Pressure

1 atm

Power

3.73 kW

Specification sheet

Section 16.1.5

Energy balance calculations

Section 25.3.3

Costing data

Section 17.1

15.1.4 Bin Blender
Bin blenders are used in this process. The primary purpose of blending is to lubricate the
formulation to prevent the tablets from sticking to the punches in the tablet press. A bin blender
consists of a blending container that is rotated with the help of a drive motor. The rotation of the
blender causes the particles to be mixed gently with low shear to obtain a uniform mixture. The
motor power was obtained by contacting an LB Bohle sales representative.

97

Unit

BD-1(B) & BD-2(B)

Type

Batch

Material

AISI 304 Stainless steel

Operating temperature

25°C

Pressure

1 atm

Power

25.5 kW

Specification sheet

Section 16.1.6

Energy balance calculations

Section 25.3.4

Costing data

Section 17.1
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15.1.5 Rotary Tablet Press
The tablet press was selected from a vendor. The tablet press is GEA’s MODUL rotary
tablet press. The motor power was obtained from GEA.
Unit

TP-1(B)

Type

Tablet Press

Material

Stainless Steel

Operating Temperature

32°C

Pressure Change

1 atm

Motor Power

6 kW

Specification Sheet

Section 16.1.7

Energy Balance Calculations

Section 25.3.5

Costing Data

Section 17.1
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15.1.6 Tablet Coater
The batch tablet coater was selected from a vendor. The batch tablet coater is Thomas
Engineering’s Accela Cota Pro. Similar to the granulators in Section 15.1.1, capital cost
estimates for the entire system were obtained by contacting a representative from Thomas
Engineering, however the heat exchanger, pumps, and blower were designed independently to
determine the utility requirements accurately. The motor power required for the pump was
provided by Thomas Engineering.
Unit

TC-1(B)

Type

Batch Fully Perforated Pan

Material

Stainless Steel

Operating Temperature

45°C

Pressure Change

1 atm

Motor Power

5.6 kW

Specification Sheet

Section 16.1.8

Energy Balance Calculations

Section 25.3.6

Costing Data

Section 17.1
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Unit

HX-2(B)

Type

Counter-Current Heat Exchanger

Material

Stainless Steel

Pressure

1 atm

Motor Power

52 kW

Specification Sheet

Section 16.1.9

Design Calculations

Section 25.4.1

Unit

BL-2(B)

Type

Centrifugal Blower

Material

Stainless Steel

Motor Power

113 kW

Specification Sheet

Section 16.1.11

Design Calculations

Section 25.3.1

Unit

PM-1

Type

Peristaltic Pump

Material

Stainless Steel

Pressure

1 atm

Motor Power

Negligible

Specification Sheet

Section 16.1.10
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Section 15.2 Equipment List and Unit Descriptions for the Continuous Process
15.2.1 Twin Screw Granulator
The Pharma 24 model Thermo-Fisher twin-screw granulator was chosen for this process,
as it is suitable for a range of solid throughputs that includes the one demanded by this process.
Electricity requirements were obtained from a Thermo-Fisher representative over a phone call.
The same pump model described in section 15.1.1 is for this system.
Unit

GR-1(C)

Type

Continuous Twin-Screw Wet Granulator

Material

Stainless Steel

Operating Temperature

25ºC

Pressure

1 atm

Motor Power

11 kW

Specification Sheet

Section 16.2.1

Energy Balance Calculations

Section 25.3.1

Costing Data

Section 17.1

Unit

PM-1(C)

Type

Peristaltic Pump

Material

Stainless Steel

Pressure

1 atm

Motor Power

Negligible

Specification Sheet

16.2.2
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15.2.2 Continuous Fluid Bed Dryer
By recommendation from the twin-screw granulator vendor, a continuous fluid bed
granulator was selected from the Glatt MODCOS continuous manufacturing line for its
compatibility with the twin-screw granulator described in section 15.2.1. Consistent with the
methods described in section 15.1.1, the heat exchanger and blower were designed independently
of the system to accurately estimate utility requirements. The same assumptions made in section
15.1.1. hold for these calculations.
Unit

DR-1(C)

Type

Continuous Fluid Bed Dryer

Material

Stainless Steel

Operating Temperature

40ºC

Pressure

1 atm

Motor Power

12 kW

Specification Sheet

Section 16.2.3

Energy Balance Calculations

Section 25.3.2

Costing Data

Section 17.1
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Unit

BL-1(C)

Type

Centrifugal Blower

Material

Stainless Steel

Motor Power

5 kW

Specification Sheet

Section 16.2.5

Design Calculations

Section 25.3.1

Unit

HX-1(C)

Type

Counter-Current Heat Exchanger

Material

Stainless Steel

Pressure

1 atm

Motor Power

52 kW

Specification Sheet

Section 16.2.4

Design Calculations

Section 25.4.1
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Section 15.2.3 Mill
The same equipment is used for milling in both batch and continuous processes as the
equipment can handle both batch and continuous throughputs. The motor power for the mill in
the continuous process is lower because of the lower throughput in the continuous process. A
lower amount of energy is needed to mill the lower throughput to the mill for the continuous
process. Section 15.1.3 includes further information about the Quadro FlexSift S20.
Unit

ML-1(C)

Type

Continuous

Material

304 stainless steel, 316 stainless steel for
product contact parts

Operating temperature

25°C

Pressure

1 atm

Power

0.55 kW

Specification Sheet

Section 16.2.6

Energy balance calculations

Section 25.3.3

Costing data

Section 17.1
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Section 15.2.4 Continuous Blender
Based on the recommendation of our project author, the continuous blender was selected
for the continuous manufacturing process. Gericke was selected as the equipment manufacturer
due to its stellar reputation in the pharmaceutical industry. Continuous blenders are tubular in
design with inputs fed at one end and outputs leaving at the other end. These blenders contain a
motor-driven shaft present axially in the center of the blender with many blades on the surface of
the shaft. The rotation of the shaft and blades mixes the inputs added to the blender and
facilitates the motion of the material through the blender.
Unit

BD-1(C) & BD-2(C)

Type

Continuous

Material

Stainless steel

Operating temperature

25°C

Pressure

1 atm

Power

0.37 kW

Specification sheet

Section 16.2.7

Energy balance calculations

Section 25.3.4

Costing data

Section 17.1
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Section 15.2.5 Continuous Tablet Press
The same tablet press that is used for the batch process, will be used for the continuous
process. See section 15.1.5.
Unit

TP-1(C)

Type

Tablet Press

Material

Stainless Steel

Operating Temperature

32°C

Pressure Change

1 atm

Motor Power

6 kW

Specification Sheet

Section 16.2.8

Energy Balance Calculations

Section 25.3.5

Costing Data

Section 17.1
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Section 15.2.6 Continuous Tablet Coater
The continuous tablet coater was selected from a vendor. The continuous tablet coater is
Thomas Engineering’s Flex CTC continuous coater. Consistent with the methods described in
section 15.1.6, the heat exchanger, pump, and blower were designed independently of the system
to accurately estimate utility requirements. The motor power required for the pump was provided
by Thomas Engineering.
Unit

TC-1(C)

Type

Continuous Fully Perforated Pan

Material

Stainless Steel

Operating Temperature

39°C

Pressure Change

1 atm

Motor Power

1.5 kW

Specification Sheet

Section 16.2.9

Energy Balance Calculations

Section 25.3.6

Costing Data

Section 17.2
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Unit

HX-2(C)

Type

Counter-Current Heat Exchanger

Material

Stainless Steel

Pressure

1 atm

Motor Power

52 kW

Specification Sheet

Section 16.2.10

Design Calculations

Section 25.4.1

Unit

BL-2(C)

Type

Centrifugal Blower

Material

Stainless Steel

Motor Power

22 kW

Specification Sheet

Section 16.2.12

Design Calculations

Section 25.3.1

Unit

PM-1(C)

Type

Peristaltic Pump

Material

Stainless Steel

Pressure

1 atm

Motor Power

Negligible

Specification Sheet

16.2.11
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Section 16: Specification Sheets
Section 16.1 Batch Process Specification Sheets
16.1.1. Fluid Bed Granulator and Dryer
While the heat exchangers, blowers, and pumps are included in the capital costs of the
system, they were each designed independently to accurately approximate utilities based off the
demanded design specifications and are thus reported independently below.

Description and Function

Vendor
Operation
Material Input

Characteristics

GR-1(B)/DR-1(B)
The fluid bed granulator and dryer is a single, large, vessel
with a working volume of 5,000 L. The vessel is designed
to be a top-spray granulator, with a nozzle at the top
through which binder solution is pumped. The vessel is
equipped with a blower and heat exchanger at the bottom
through which air travels before it enters through the
bottom of the chamber at a specified flow rate and
temperature. The system is also equipped with an air filter
between the blower and heat exchanger to ensure that only
clean air enters the system. Exhaust air exits the system
through the exhaust pipe at the top of the vessel.
Glatt
Batch
API
1,000 kg
Excipients
540 kg
Binder Solution
344 kg
Air
2,800-5,200 m3/h
Model
GCCG Pro
Construction Materials
Stainless Steel
Size
5,000 L
Motor Power
53 kW
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16.1.2 HX-01 Heat Exchanger

Species
Temperature (ºC)
Pressure (atm)
Vapor Fraction
Mass Flow (kg/h)
Volumetric Flow (m3/h)

Species
Temperature (ºC)
Pressure (atm)
Vapor Fraction
Mass Flow (kg/h)
Volumetric Flow (m3/h)

HX-1(B) (Granulation Setting)
Cold in
Cold out
Hot in
Air
Air
Steam
25
55
152
2
2
3.4
1
1
1
3,000
3,000
35
2,500
2,800
n/a

HX-1(B) (Drying Setting)
Cold in
Cold out
Air
Air
25
75
2
2
1
1
5,200
5,200
4,400
5,200

Hot in
Steam
152
3.4
1
81
n/a

Hot Out
Steam
152
3.4
0
35
n/a

Hot Out
Steam
152
3.4
0
81
n/a

HX-1(B) Design Data
Type
Shell-in-tube, Countercurrent, Fixed Head
2
Effective Surface Area (m )
0.30-0.95
LMTD (ºC)
111-99
2
Heat Transfer Coefficient (W/m K)
850
Tube Side Material
Stainless Steel
Shell Side Material
Stainless Steel
No. Tubes/Pass
1
No. Passes
1
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16.1.3 PM-1(B) Binder Pump

Description and Function

Vendor
Operation
Material Input
Characteristics

PM-1(B)
Peristaltic pump used to pump binder solution in the
granulator during granulation. Modeled separately to
accurately estimate utility costs.
Venderflex
Batch
Binder Solution (12%)
10 kg/h
Model
Vantage 3000
Construction Materials
Stainless Steel
Capacity
0.9 mL/min to 1.21 L/min
Motor Power
0.02 kW

16.1.4 BL-1(B) Air Blower

Type
Material
Blower Efficiency
Motor Efficiency

BL-1(B) Design Data
Centrifugal Blower
Stainless Steel
0.75
0.92

Pressure Increase
Air Volumetric flow rate
Power Consumption

BL-1(B) Granulator Settings
0.2 atm
2,800 m3/h
90 kW

Pressure Increase
Air Volumetric flow rate
Power Consumption

BL-1(B) Dryer Settings
1 atm
5,200 m3/h
166 kW
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16.1.5 ML-1(B) Mill
It should be noted that milling is a semi-continuous operation, and that the duration of
milling for the batch process is three hours. Therefore, the throughput from the mill is
approximately 390 kg/hr, with API and excipient throughputs of 333 kg/hr and 187 kg/hr
respectively.

Description and Function

Vendor
Operation
Materials Handled

Characteristics

ML-1(B)
This equipment consists of a powder processing head, which is
attached to the SMARTdetect Interface that controls and
automatically adjusts the RPM at which the system is operating.
The head also contains a gearbox inside it. The interface is
attached to a motor that provides energy for the rotation of the
milling chamber. The control panel is present below the motor
and can be used by the operator to set the mill rotational speed.
Quadro
Batch
Input (kg)
Output (kg)
API
1000
1000
Excipients
560
560
Model
Quadro FlexSift S20
Construction
304 stainless steel, 316 stainless steel
Materials
product contact parts
Size of production 30.6 L
head
Volume of
2.5 L
production head
occupied by
powder
Motor Power
3.73 kW
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16.1.6 BD-1(B) & BD-2(B) Bin Blender
The LB Bohle container blender (PM-6000) is filled to 85% of its total capacity as
headspace is required for blending to be carried out properly.

Description and
Function

Vendor
Operation
Materials Handled

Characteristics

BD-1(B) & BD-2(B)
There are two blenders in the batch process—one pre-blender before
the granulator, and one blender after the mill. The same model is
used for both. This equipment consists of a clamping cage to hold the
blend container during operation and a motor that provides energy
for the rotation of the container. A control panel is present near the
equipment for the operator to set parameters such as the blender
rotational speed.
LB Bohle
Batch
For BD-1(B):
Input 1 (kg)
Input 2 (kg) Output (kg)
API
1000
0
1000
Excipients
0
520
520
For BD-2(B):
Input 1 (kg)
Input 2 (kg) Output (kg)
API
1000
0
1000
Excipients
560
360
920
Model
LB Bohle container blender PM 6000
Construction
Stainless steel
Materials
Size for both
6000 L
blender and preblender
Motor Power

25.5 kW
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16.1.7 TP-1(B) Rotary Tablet Press
It should be noted that compression is a continuous operation, and that the duration of
compression for the batch process is 21 hours. Therefore, the throughput from the tablet press is
approximately 91 kg/h.

Description and Function

Vendor
Operation
Material Input
Characteristics

TP-1(B)
The MODUL™ P rotary tablet press compresses the powder
(API and excipient) blend into tablets. The characteristics of
this equipment were obtained from GEA’s website for the
MODUL™ P rotary tablet press.
GEA
Compression
Powder blend
1920 kg
Model
MODUL™ P rotary tablet
press
Construction Materials
Stainless Steel
Size
W = 1030 mm x D = 1555
mm x H = 2170 m – 2.500 kg
Motor Power
6 kW
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16.1.8 TC-1(B) Batch Tablet Coater
The heat exchangers, blowers, and pumps are included in the capital costs of the system,
but they were each designed independently to accurately approximate utilities based off the
demanded design specifications and are thus reported independently below.

Description and Function

Vendor
Operation
Material Input
Characteristics

TC-1(B)
The Thomas Accela-Cota® is a fully perforated coating drum
that revolutionized the coating manufacturing process when it
was introduced in 1969. This machine continues to set the
standards for tablet coating with unrestricted air flow,
thermodynamic efficiency, and flexibility [55]. The
characteristics for this tablet coater can be found in the
equipment brochure (Section 25.10.8). The tablet coater also
includes a heat exchanger, pump and blower, which are
designed separately to perform utility calculations.
Thomas Engineering
Tablet Coating
Uncoated Tablets
1920 kg
Coating solution
800 kg
Model
Thomas Accela-Cota®
Construction Materials
Stainless Steel
Size
W=1,800 mm x H=2,200 mm
x D =2,550 mm – 2.500 kg
Motor Power
5.6 kW
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16.1.9 HX-2(B) Heat Exchanger
HX-2(B) Design Data
Type
Shell-in-tube, Countercurrent, Fixed Head
Effective Surface Area (m2)
3.4
LMTD (ºC)
99
Heat Transfer Coefficient (W/m2K)
850
Tube Side Material
Stainless Steel
Shell Side Material
Stainless Steel
No. Tubes/Pass
1
No. Passes
1

Species
Temperature (ºC)
Pressure (atm)
Vapor Fraction
Mass Flow (kg/h)
Volumetric Flow (m3/h)

Cold in
Air
25
2
1
18,100
15,300

HX-2(B) Settings
Cold out
Air
75
2
1
18,100
17,900

Hot in
Steam
152
3.4
1
281
n/a

Hot Out
Steam
152
3.4
0
281
n/a
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16.1.10 PM-2(B) Coater Pump
See Section 16.1.3
16.1.11 BL-2(B) Coater Air Blower

Type
Material
Blower Efficiency
Motor Efficiency

Pressure Increase
Air Volumetric flow rate
Power Consumption

BL-2(B) Design Data
Centrifugal Blower
Stainless Steel
0.75
0.92
BL-2(B) Settings
0.2 atm
17,900 m3/h
460 kW
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Section 16.2 Continuous Process Specification Sheets
16.2.1. GR-1(C) Twin Screw Granulator
While the heat exchangers, blowers, and pumps are included in the capital costs of the
system, they were each designed independently to accurately approximate utilities based off the
demanded design specifications and are thus reported independently below.

Description and Function

Vendor
Operation
Material Input

Characteristics

GR-1(C)
The continuous twin-screw wet granulator is composed of
two co-rotating screws enclosed in a barrel. There are two
kneading zones separated by conveying zones. Geometry
of the kneading and conveying screw elements is
customizable, and screw speed can be set. The equipment
comes with feeders, a pump for the binder fluid, and an
automated interface.
Thermo Fisher Scientific
Continuous
API
41 kg/h
Excipients
21 kg/h
Binder Solution
10 kg/h
Model
GCCG Pro
Construction Materials
Pharma 24
Capacity
70-85 kg/h
Motor Power
20 kW

16.2.2 PM-1(C) Binder Pump
See Section 16.1.3
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16.2.3 DR-1(C) Continuous Fluid Bed Dryer
DR-1 (C)
The continuous fluid bed dryer comes complete with
blowers and heat exchangers to blow air in from
underneath the vessel to dry the moving granules at
specified temperatures and volumetric flow rates. Solids
are transported pneumatically through the system and are
fluidized by the hot air during drying. Exhaust air exits
through exhausts pipes out the top of the vessel.
Glatt
Continuous
API
41 kg/h
Excipients
23 kg/h
Air
1,200 m3/h
Model
MODCOS l-line
Construction Materials
Stainless Steel
Capacity
50-100 kg/h
Motor Power
12 kW

Description and Function

Vendor
Operation
Material Input

Characteristics

16.2.4 HX-1(C) Heat Exchanger

Species
Temperature (ºC)
Pressure (atm)
Vapor Fraction
Mass Flow (kg/h)
Volumetric Flow (m3/h)

HX-1(C) Settings
Cold in
Cold out
Air
Air
25
55
2
2
1
1
1,230
1,230
1,040
1,150

Type
Effective Surface Area (m2)
LMTD (ºC)
Heat Transfer Coefficient (W/m2K)
Tube Side Material
Shell Side Material
No. Tubes/Pass
No. Passes

Hot in
Steam
152
3.4
1
18
n/a

Hot Out
Steam
152
3.4
0
18
n/a

HX-1(C) Design Data
Shell-in-tube, Countercurrent, Fixed Head
0.23
99
850
Stainless Steel
Stainless Steel
1
1
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16.2.5 BL-1(C) Air Blower
Type
Material
Blower Efficiency
Motor Efficiency

Pressure Increase
Air Volumetric flow rate
Power Consumption

BL-1(C) Design Data
Centrifugal Blower
Stainless Steel
0.75
0.92
BL-1(C) Settings
0.1 atm
1,200 m3/h
37 kW

16.2.6 ML-1(C) Mill
The motor power for the mill in the continuous process is lower because of the lower
throughput in the continuous process. A lower amount of energy is needed to mill the lower
throughput to the mill for the continuous process.

Description and Function

Vendor
Operation
Materials Handled

Characteristics

ML-1(C)
The same equipment is used for both the batch and continuous
process. This equipment consists of a powder processing head,
which is attached to the SMARTdetect Interface that controls and
automatically adjusts the RPM at which the system is operating.
The head also contains a gearbox inside it. The interface is
attached to a motor that provides energy for the rotation of the
milling chamber. The control panel is present below the motor
and can be used by the operator to set the mill rotational speed.
Quadro
Continuous
Input (kg/hr)
Output (kg/hr)
API
41
41
Excipients
23
23
Model
Quadro FlexSift S20
Construction
304 stainless steel, 316 stainless steel
Materials
product contact parts
Size of production 30.6 L
head
Volume of
2.5 L
production head
occupied by
powder
Motor Power
0.55 kW
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16.2.7 BD-1(C) & BD-2(C) Continuous Blender
BD-1(C) & BD-2(C)
Description and
Similar to the batch process, there are two blenders in the continuous
Function
process—one pre-blender before the granulator, and one blender after
the mill. The same model is used for both. This equipment consists of
a tubular continuous mixing module with feeders for the inputs to the
blender. It also contains a motor that provides energy for the rotation
of the shaft located axially in the center of the blender with blades
covering its surface. Blend homogeneity is tested using a near-infrared
(NIR) probe present at the output end of the mixer.
Vendor
Gericke
Operation
Continuous
Materials Handled
For pre-blender:
Input 1 (kg/hr) Input 2 (kg/hr)
Output (kg/hr)
API
41
0
41
Excipients
0
21
21
For blender:

Characteristics

API
Excipients
Model
Construction
Materials
Dimensions of
continuous
blender
Size of mixing
module for both
blender and preblender
Motor Power

Input 1 (kg/hr) Input 2 (kg/hr)
Output (kg/hr)
41
0
41
23
15
38
Gericke continuous blender GCM-450
Stainless steel
Length (m)

1.8

Width (m)

1.6

Height (m)

1.65

10 L

0.37 kW
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16.2.8 TP-1(C) Rotary Tablet Press

Description and Function

Vendor
Operation
Material Input
Characteristics

TP-1(C)
The MODUL™ P rotary tablet press compresses the powder
(API and excipient) blend into tablets. The characteristics of
this equipment were obtained from GEA’s website for the
MODUL™ P rotary tablet press.
GEA
Compression
Powder blend
79 kg/hr
Model
MODUL™ P rotary tablet
press
Construction Materials
Stainless Steel
Size
W = 1030 mm x D = 1555
mm x H = 2170 m – 2.500 kg
Motor Power
6 kW
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16.2.9 TC-1(C) Continuous Tablet Coater
While the heat exchangers, blowers, and pumps are included in the capital costs of the
system, they were each designed independently to accurately approximate utilities based off the
demanded design specifications and are thus reported independently below.

Description and Function

Vendor
Operation
Material Input
Characteristics

TC-1(C)
The Thomas Flex CTC® Continuous Tablet Coater extends
film coating technology from the typical batch process to a
fast and efficient continuous process. The characteristics for
this tablet coater can be found in the equipment brochure
Section 25.10.10. The tablet coater also includes a heat
exchanger, pump, and blower, which are designed separately
to perform utility calculations. This equipment has 22 spray
nozzles that introduce the coating solution to the tablets and
also includes a wash-in-place system [16].
Thomas Engineering
Tablet Coating
Uncoated Tablets
79 kg/hr
Coating solution
33 kg/hr
Model
Thomas FLEX CTC®
Continuous Tablet Coater
Construction Materials
Stainless Steel
Size
15’3” ft x 4’2” ft x 10’9” ft [
4.57m x 1.21m x 3.04m]
Motor Power
1.5 kW
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16.2.10 HX-2(C) Heat Exchanger
HX-2(C) Design Data
Type
Shell-in-tube, Countercurrent, Fixed Head
Effective Surface Area (m2)
0.67
LMTD (ºC)
110
Heat Transfer Coefficient (W/m2K)
850
Tube Side Material
Stainless Steel
Shell Side Material
Stainless Steel
No. Tubes/Pass
1
No. Passes
1

Species
Temperature (ºC)
Pressure (atm)
Vapor Fraction
Mass Flow (kg/h)
Volumetric Flow (m3/h)

HX-2(C) Settings
Cold in
Cold out
Air
Air
25
57
2
2
1
1
7,300
7,300
6,200
6,800

Hot in
Steam
152
3.4
1
113
n/a

Hot Out
Steam
152
3.4
0
113
n/a

16.2.11 PM-2(C) Coater Pump
See Section 16.1.3
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16.2.12 BL-2(C) Coater Air Blower

Type
Material
Blower Efficiency
Motor Efficiency

Pressure Increase
Air Volumetric flow rate
Power Consumption

BL-2(C) Design Data
Centrifugal Blower
Stainless Steel
0.75
0.92
BL-2(C) Settings
0.1 atm
6,800 m3/h
175 kW
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Section 17: Equipment Summary
Section 17.1 Equipment Purchase Cost
For the economic analysis, the purchase price of the equipment was a strong influence on
the determined profitability of each process. SuperPro Designer was used to estimate the costs
for the different pieces of equipment that are used for both processes. Upon assessment, it was
determined that the values provided by SuperPro were not realistic. Additionally, when
developing models on SuperPro, some of the equipment needed for the process was not available
to add to the model. This was a greater problem for the continuous model, as SuperPro had no
options for modeling the twin screw granulator and blender. It was decided that it would be best
not to rely on the values for purchase costs given by SuperPro.
Concepts and correlations from Seider et al.’s textbook were used to calculate purchase
costs of the different pieces of equipment (Section 25.6). These prices were significantly lower
than vendor quotes, as shown in Table 17.1.1 and Table 17.1.2. A reason for the inaccuracy of
these values could be the assumptions made to perform the calculations, as the correlations were
used even when the size factors for the equipment were outside the suitable range. For some
equipment, no correlations were available. Thus, the correlations assumed to model those pieces
of equipment were not reflective of the actual equipment used in the processes, as shown in
Section 25.6.
Purchase cost estimates were also obtained from industrial vendors. It was difficult to
contact some vendors, and some could not give exact estimates due to confidentiality. In some
cases, the quotes given for the equipment did not match our batch size or throughput. To get a
price that was more suitable for the equipment in our processes, the vendor equipment cost was
scaled using the sixth-tenths rule. Additionally, literature and reseller websites were also helpful
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sources for obtaining purchase prices. For all the process equipment with multiple vendor quotes,
the most precise and reliable vendor was selected. Table 17.1.1 and Table 17.1.2 summarize all
the sources that were used to obtain purchasing cost information and explain which prices were
used for the economic analysis and why. For most of the equipment, prices from vendors were
used, as they appeared to be the most reliable, and those prices were scaled appropriately when
necessary. Table 17.1.2 also includes a cost for conveying, and information on how this cost was
calculated can be found in Section 25.6.6.
After each process is complete, the tablets are stored in Rhino BV-60 bins. Each bin has a
volume of 2,500 L, and it was suggested that about 2,000 L of tablets should be stored in a
singular bin to avoid crushing the tablets. Since both processes produce the same number of
tablets, about 4,000 L/day for the batch process and 3,940 L/day for the continuous process, two
bins would be needed per day for each process to store the tablets. A bulk density of 0.5 kg/L
was used to determine these volumes. The cost of the storage bins is included as a one-time
equipment purchase cost in the profitability analyses. However, storage bins would need to be
purchased annually. As the same number of bins are required for both processes, cost of the bins
will not affect the results of the economic analyses when comparing the batch and continuous
processes. Also, the costs of the bins are small compared to the costs of other pieces of
equipment and do not significantly affect the profitability analyses. Tabulated purchase costs do
not include pumps, heat exchangers and blowers as they are included in the purchase cost
estimates for the granulators, dryers, and coaters, and were only modeled separately to estimate
utility requirements.
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Table 17.1.1 shows that the total purchase cost for the batch process would be
$6,355,000 and Table 17.1.2 shows that the total purchase cost for the batch process would be
$5,026,000.
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Table 17.1.1 Purchase Costs for Equipment for the Batch Process
Batch Purchase Costs ($)
Other
(Reseller
or
SuperPro Calculated Vendor 1 Vendor 2 Vendor 3 Literature) Selected
($)
($)
($)
($)
($)
($)
value($)
Granulator
+
Dryer
23,611,000
PreBlender
6,919,500
Blender
Mill

Tablet
Press
Tablet
Coater
Rhino BV60 bins

267,000 3,500,000 1,920,000 1,000,000 1,238,321
30,000

140,000

700,000

-

410,222

6,919,500

30,000

140,000

700,000

-

410,222

171,000

20,000

45,000

55,000

65,500

200,411

708,000

32,000

196,000

510,000

-

-

29,450,000

143,000

500,000

-

-

-

-

-

400,000

-

-

--

Total

Reasons for selected values
A Glatt representative provided a
reliable quote. Other vendors provided
3,500,000 rough estimates
LB Bohle representative provided
700,000 reliable quote
LB Bohle representative provided
700,000 reliable quote
Quadro representative provided
45,000 reliable quote
GEA representative provided a reliable
quote with an associated throughput
that could be scaled down to match
510,000 the throughput for this process.
Thomas Engineering representative
500,000 provided reliable quote
Bonar Plastics representative provided
400,000 reliable quote

$6,355,000

Table 17.1.2 Purchase Costs for Equipment for the Continuous Process
Continuous Purchase Costs ($)
SuperPro
($)
Granulator

Calculated Vendor 1
($)
($)

Other
(Reseller or
Vendor 2 Vendor Literature) Selected
($)
3 ($)
value($)
($)

36,000

78,000

735,000 1,000,000

-

650,000

Dryer

3,058,000

92,000

196,500

-

-

45,000

Pre-Blender

3,058,000

30,000

1,000,000

-

-

-

Blender

3,058,000

30,000

1,000,000

-

-

-

68,000

20,000

45,000

55,000

65,500

-

584,000

31,000

196,000

471,000

-

-

35,000,000
-

234,000
25,400

888,000
-

-

-

725,000
-

-

-

400,000

-

-

-

Mill

Tablet Press

Tablet Coater
Conveying
Rhino BV-60
bins
Total

Reasons for selected values
Thermo-Fisher representative provided
1,000,000 reliable quote
Glatt representative provided a reliable quote
with an associated throughput that could be
scaled down to match the throughput for this
196,500 process.
Gericke representative provided reliable
1,000,000 quote
Gericke representative provided reliable
1,000,000 quote
Quadro representative provided reliable
45,000 quote
GEA representative provided a reliable quote
with an associated throughput that could be
scaled down to match the throughput for this
471,000 process.
Thomas Engineering representative provided
a reliable quote with an associated
throughput that could be scaled down to
888,000 match the throughput for this process.
25,400 Calculated using Seider et al.
Bonar Plastics representative provided
reliable quote
400,000

$5,026,000
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Section 17.2 Equipment Bare Module Cost
Table 17.2.1 and Table 17.2.2 display the equipment purchase costs required for the
batch and continuous processes respectively. All of the equipment bare module costs were
obtained using the purchase prices highlighted in Section 17.1, the equations detailed in Seider et
al.’s “Product and Process Design Principles”, and the CBE 459 Profitability Analysis 4.0
spreadsheet. The equations used to determine the bare module costs can be found in Section
25.7. A CE cost index of 600 was used to account for the fact that the index has fluctuated over
the past few years and this value is approximately the median over the past few years.
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Table 17.2.1 Batch Equipment Cost Summary
Unit-ID
Type
Purchase
Cost($)
BD-1(B)
GR-1(B)/DR1(B)
ML-1(B)
BD-2(B)
TP-1(B)
TC-1(B)
Rhino BV-60
bins

Process
Machinery
Process
Machinery
Process
Machinery
Process
Machinery
Process
Machinery
Process
Machinery
Storage

Bare Module Unit Type
Cost

$700,000

Bare
Module
Factor, FBM
3.21

$2,247,000

Blender

$3,500,000

3.21

$11,235,000

$45,000

2.30

$103,500

Granulator
and Dryer
Mill

$700,000

3.21

$2,247,00

Blender

$510,000

3.21

$1,637,100

Tablet Press

$500,000

3.21

$1,605,000

Tablet Coater

$400,000

1.00

$400,000

Storage Bins

Total Bare Module Cost: $19,474,600
Table 17.2.2 Continuous Equipment Cost Summary
Unit-ID
Type
Purchase
Bare Module Bare Module
Cost($)
Factor, FBM Cost
BD-1(C)
Process
$1,000,000
3.21
$3,210,000
Machinery
GR-1(C)
Process
$1,000,000
3.21
$3,210,000
Machinery
DR-1(C)
Process
$196,500
2.06
$404,790
Machinery
ML-1(C)
Process
$45,000
2.30
$103,500
Machinery
BD-2(C)
Process
$1,000,000
3.21
$3,210,00
Machinery
TP-1(C)
Process
$471,000
3.21
$1,511,910
Machinery
TC-1(C)
Process
$888,000
3.21
$2,850,480
Machinery
Rhino BV-60 Storage
$400,000
1.00
$400,000
bins
Conveying
Other
$25,427
1.61
$40,937.47
Equipment
Total Bare Module Cost: $14,941,617.47

Unit Type
Blender
Granulator
Dryer
Mill
Blender
Tablet Press
Tablet Coater
Storage Bins
Conveyor
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Section 18: Total Capital Investment Summary
The Profitability Analysis Spreadsheet 4.0 provided by the course was used to conduct
economic analyses for our manufacturing facilities. The results obtained from this spreadsheet
will also be discussed in Sections 19 and 21.
The equipment purchase costs discussed in Section 17 were inputted into the spreadsheet
and classified under “Process Machinery” or “Storage”. “Process Machinery”, as defined by
Seider et al, is equipment that is selected from standard sizes supplied by a vendor and often
includes a drive motor to satisfy the energy requirement. “Storage” refers to bins that are used to
store the tablets after production is complete. The bins used for storage are Rhino single wall
bins (BV-60) from Bonar Plastics. Two bins are used to store a batch (2000 kg) of tablets. All
other equipment used in both manufacturing processes was classified as process machinery
because it would be bought from a vendor.
Section 18.1 Batch Process
The total bare module costs include purchasing, direct, and indirect installation costs for
the equipment. For all equipment except the mill, the bare module factors are not known, and so
the default value of 3.21 given in the spreadsheet was used. For the mill, a bare module factor of
2.3 computed by Guthrie was used [51]. For the storage bins, a bare module factor of 1 was used
as the installation costs for the bins are negligible.
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Table 18.1.1: Total bare module costs for the batch manufacturing facility

The default factors given in the spreadsheet were used to calculate the costs of site
preparation, service facilities, contingencies, land, and startup. There is no cost of royalties as the
drug being manufactured is a generic drug and is not under any patent. The site factor used was
1.10, as the plant will be built in New Jersey (U.S. Northeast).
Table 18.1.2: Factors for calculating total permanent investment

The total permanent investment of the batch manufacturing plant was calculated to be
$31.1 million.
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Table 18.1.3: Total permanent investment for batch manufacturing facility

To calculate the working capital, the number of days for accounts receivable and payable
were set to zero days and 30 days respectively. As the API is obtained from within the company,
there are no payables on the API. Also, as the tablets are transferred for packaging to another
facility within the company, there are no receivables on the tablets. The excipients are purchased
in bulk from a chemical company, Ningbo Samreal Chemical Co. in China, at $1 per bag of 20
kg [41]. This price was given for magnesium stearate and for simplicity, it is assumed to be the
same for all excipients needed for the process. The price of excipients can vary based on the type
of excipients being used in the manufacturing process. The accounts payable for the excipients is
set to 30 days. The product inventory was set to zero days based on a recommendation from
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Professor Vrana. The raw material inventory and cash reserves were kept at the default value of
two days and 30 days respectively.
Table 18.1.4: Factors for calculating working capital

The working capital was used to calculate the total capital investment, which was $31.6
million.
Table 18.1.5: Total capital investment and working capital
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Section 18.2 Continuous Process
The same calculations described in Section 18.1 were done for the continuous process.
Similar to the batch process, the equipment for the continuous process is classified under
“Process Machinery”. The exceptions are the conveying and storage equipment. The conveyors
are classified under “Other Equipment”, and the storage bins are classified under “Storage”. Two
Rhino single wall bins (BV-60) from Bonar Plastics are used to store the tablets made
continuously in one day.
The total bare module costs are calculated by multiplying the equipment purchase costs
by bare module factors. The bare module costs account for purchase, direct, and indirect
installation costs for the equipment. For the mill, dryer, and conveyor, bare module factors of
2.3, 2.06, and 1.61 respectively computed by Guthrie were used [51]. For the storage bins, a bare
module factor of 1 was used as the installation costs for the bins are negligible.

Table 18.2.1: Total bare module costs for the continuous manufacturing facility

Similar to the batch process, the default factors given in the spreadsheet were used to
calculate the costs of site preparation, service facilities, contingencies, land, and startup for the
continuous process. There is no cost of royalties as the drug being manufactured is a generic
drug and is not under any patent. The site factor used was 1.10, as the plant will be built in New
Jersey (U.S. Northeast).
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Table 18.2.2: Factors for calculating total permanent investment

The total permanent investment of the continuous manufacturing facility was calculated
to be $23.9 million.
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Table 18.2.3: Total permanent investment for continuous manufacturing facility

To calculate the working capital, the same number of days as the batch process were set
for accounts receivable, cash reserves, accounts payable, raw material and product inventories.
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Table 18.2.4: Factors for calculating working capital

The working capital was used to calculate the total capital investment, which came out to
$24.2 million.

Table 18.2.5: Total capital investment and working capital
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Section 19: Operating Cost— Cost of Manufacture
Section 19.1 Operating Costs for the Batch Process
19.1.1 General Operating Considerations
The batch manufacturing plant will be located in New Jersey and will run 24 hours a day,
330 days per year. Each batch takes 46.5 hours to complete (batch time), but a single batch is
completed every 24 hours (cycle time). The month off per year will be used for maintenance and
vacation days. No time needs to be taken off for cleaning because there is enough equipment idle
time during the batch cycle that the equipment can be cleaned every eight batches without
interrupting operation. Costs of cleaning have been determined to be negligible, and details are
available in the appendix. It will take one year to design the facility, one year to build the facility
and the plant will produce for 21 years. The facility will be designed in 2022, constructed in
2023, and production will begin in 2024.

19.1.2 Raw materials, Utilities, Byproducts, and General Expenses
It is assumed that the API is provided without cost to the manufacturing plant. The API to
excipient ratio by weight (drug load) is 1:1. The excipients are purchased in bulk from a
chemical company, Ningbo Samreal Chemical Co. in China, at $1 per bag of 20 kg [41]. This
price was given for magnesium stearate and for simplicity, it is assumed to be the same for all
excipients needed for the process. The price of excipients can vary based on the type of
excipients being used in the manufacturing process.
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Table 19.1.1 Raw Material Requirements for the Batch Process
Raw Material

Required

Cost ($/kg)

Daily Cost ($)

Annual Cost ($)

(kg/batch)
API

1,000

0

0

0

Excipients

1,000

0.05

50

16,500

The utilities used in this process include steam, electricity, and process water. Steam is
used in each of the heat exchangers, electricity is used to power each piece of equipment, and
process water is used in both the binder and coating solution. Table 19.1.2 reflects the cost per
unit of each of the utilities, while Table 19.1.3 reflects the utility requirements for each piece of
equipment in the process.

Table 19.1.2 Cost of Utilities used in the Batch Process
Utility

Steam, 50 psig (3.4 atm)

Water

Electricity

Cost

$0.0132/kg

$0.27/m3

$0.07/kWh
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Table 19.1.3 Utility Requirements for the Batch Process
Unit
Steam (kg/batch)
Water (kg/batch)
BD-1(B)

Electricity
(kWh/batch)
17

GR-1(B)/DR-1(B)

480

BL-1(B)

310

HX-1(B)

630

PM-1(B)

470
304

0.1

ML-1(B)

11

BD-2(B)

17

TP-1(B)

126

TC-1(B)

34

BL-2(B)

680

HX-2(B)

1,700

PM-2(B)
Total (per batch)
Cost (daily)
Cost (annual)
Total Annual

310
711

0.12

2,300

1,000

2,500

$31

$0

$172

$10,097

$90

$56,800
$67,000

Utilities

There are no byproducts produced by this process that can be sold for profit. General
expenses include the cost of selling (transfer) expense, direct research, allocated research,
administrative expense, and management incentive compensation. Costs for each of these
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categories are calculated using suggestions from Seider, et al., and are shown in Table 19.1.4.
The target cost per tablet was $0.01, therefore sales are calculated to be $10,000,000
(1,000,000,000 tablets x $0.01/tablet = $10,000,000).

Table 19.1.4. Variable Cost Summary for the Batch Process

The total variable costs are equal to $1.90 per kg of tablets.
19.1.3 Fixed Costs—Operations, Maintenance, and Overhead
Assumptions used to determine fixed operating, maintenance, and overhead costs are
sourced from Seider, et al. Table 19.1.5 details the components of fixed operating costs for the
batch process. For the batch process, it is assumed that four operators are needed per shift, and
that there are five shifts per day. Two engineers are required at the plant for technical assistance
and manufacturing, and each are paid $200,000 annually. Additionally, one lab professional is
needed for the control laboratory and requires a salary of $200,000 annually as well. Table
19.1.6 details the breakdown of fixed maintenance costs, where TDC stands for Total
Depreciable Capital (Table 18.1.3). Table 19.1.7 details the breakdown of fixed overhead costs.
M&O (Maintenance and Operation costs) is defined as the sum of DW&B (Direct Salaries and
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Benefits) and MW&B (Maintenance Salaries and Benefits). Table 19.1.8 summarizes all fixed
costs for the batch process.

Table 19.1.5 Components of Fixed Operating Costs for the Batch
Process
Operation
Details
Operators Per Shift

4 (assuming 5 shifts)

Direct Wages and Benefits (DW&B)

$40/operator/hour

Direct Salaries and Benefits

15% of DW&B

Operating Supplies and Services

6% of DW&B

Technical Assistance to Manufacturing

$20,000/yr/operator/shift

Control Laboratory

$10,000/yr/operator/shift

Table 19.1.6 Components of Fixed Maintenance Costs for the
Batch Process
Operation
Details
Wages and Benefits (MW&B)

4.5% of TDC

Salaries and Benefits

25% of MW&B

Materials and Services

100% of MW&B

Maintenance Overhead

5% of MW&B
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Table 19.1.7 Components of Fixed Overhead Costs for the Batch
Process
Operation
Details
General Plant Overhead

7.1% of M&O

Mechanical Department Services

2.4% of M&O

Employee Relations Department

5.9% of M&O

Business Services

7.4% of M&O
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Table 19.1.8. Summary of All Fixed Costs for the Batch Process

The total fixed costs are equal to $9.84 per kg of tablets.
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Section 19.2 Operating Costs for the Continuous Process
19.2.1 General Operating Considerations
The continuous manufacturing plant will be in New Jersey and will run 24 hours a day,
330 per year. A continuous throughout of 82 kg/h will be used to produce 2,000 kg of tablets per
day and meet the annual demand of one billion tablets. The month off per year will be used for
maintenance, cleaning, and vacation days. The process will have to be shut down for cleaning the
equipment. A target process run length before cleaning was estimated by doing a sensitivity
analysis, as explained in Section 20.4. The exact amount and cost of the cleaning agent required
will be optimized by a process R&D team and is out of scope for this report. It will take one year
to design the facility, one year to build the facility, and the plant will produce tablets for 21
years. The facility will be designed in 2022, constructed in 2023, and production will begin in
2024.

19.2.2 Raw materials, Utilities, Byproducts, and General Expenses
It is assumed that the API is provided without cost to the manufacturing plant. The API to
excipient ratio by weight (drug load) is 1:1. Details about excipient pricing are included in
Section 19.1.2. Table 19.2.1 details the raw material requirements for the continuous process.
Table 19.2.1 Raw Material Requirements for the Continuous Process
Raw Material

Required (kg/hr)

Cost ($/kg)

Daily Cost ($)

Annual Cost ($)

API

41

0

0

0

Excipients

41

0.05

50

16,500
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The utilities used in this process include steam, electricity, and process water. Steam is
used in each of the heat exchangers, electricity is used to power each piece of equipment, and
process water is used in both the binder and coating solution. Table 19.2.2 reflects the cost per
unit of each of the utilities, while Table 19.2.3 reflects the utility requirements for each piece of
equipment in the process.
Table 19.2.2 Cost of Utilities used in the Continuous Process
Utility

Steam, 50 psig (3.4 atm)

Water

Electricity

Cost

$0.0132/kg

$0.27/m3

$0.07/kWh
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Table 19.2.3 Utility Requirements for the Continuous Process
Unit

Steam (kg/h)

Water (kg/h)

Electricity (kWh/day)

BD-1(C)

9

GR-1(C)

480

PM-1(C)

8.1

0.5

DR-1(C)

288

BL-1(C)

113

HX-1(C)

18

1,248

ML-1(C)

13

BD-2(C)

9

TP-1(C)

144

TC-1(C)

36

BL-2(C)

537

HX-2(C)

113

PM-2(C)

1,248
30

0.5

Total (per hour)

131

37.8

4,126

Cost (daily)

$42

$0

$288

$13,695

$81

$95,303

Cost (annual)
Total Annual

$109,080

Utilities

There are no byproducts produced by this process that can be sold for profit. General
expenses include the cost of selling (transfer) expense, direct research, allocated research,
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administrative expense, and management incentive compensation. Costs for each of these
categories are calculated using suggestions from Seider, et al., and are shown in Table 19.2.4.
The target cost per tablet was $0.01, therefore sales are calculated to be $10,000,000
(1,000,000,000 tablets x $0.01/tablet = $10,000,000).

Table 19.2.4 Variable Cost Summary for the Continuous Process

The total variable costs are equal to $1.97 per kg of tablets.
19.2.3 Fixed Costs—Operations, Maintenance, and Overhead
Assumptions used to determine fixed operating, maintenance, and overhead costs are
sourced from Seider, et al., and follow the same outline as shown in Tables 19.1.5-19.1.7, with
the exception that for the continuous process, it is assumed that only three operators are required
per shift as opposed to the four per shift required for the batch process. A summary of all the
fixed costs required for the continuous process is shown in Table 19.2.5.
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Table 19.2.5. Fixed Cost Summary for the Continuous Process

The total fixed costs are equal to $7.82 per kg of tablets.
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Section 19.3 Interpretation of Operating Costs
Through evaluation of the tables presented above, operating costs are greater for the
batch process than the continuous process. The sum of utilities, general expenses, and fixed costs
for the batch process and continuous processes are about $7.7 million and $6.2 million
respectively. Utility costs are higher for the continuous process than the batch process likely due
to constant operation of the equipment in the continuous process. In the batch process, each piece
of equipment has some amount of idle time. The significantly higher fixed costs for the batch
process is related to the demand for an extra plant operator per shift.
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Section 20: Other Important Considerations
Section 20.1 Location Determination
Some pharmaceutical manufacturing hotspots in the world are the US, China, Kenya,
UAE, and Switzerland. Initially, an international location was considered for the location of the
manufacturing facilities as 80% of active pharmaceutical ingredient (API) manufacturers are
located outside the US [25]. Most pharmaceuticals used in the US are either made in China or
India or use ingredients from those countries [25].
China and India were initially considered as locations for the manufacturing facilities.
Some benefits of choosing India or China as the location include lower transportation, labor,
infrastructure, and equipment costs [9]. Indian and Chinese firms have less environmental
regulations around buying, handling, and disposing of toxic chemicals. This leads to lower direct
costs for these businesses [9]. Additionally, there are lower barriers to market entry in India and
China. However, factors such as regulatory approval, language barriers, and importation costs
represent the cons of building the manufacturing plants in India or China.
To simplify the economic analysis and avoid the hassle of international regulations, it
was decided that the manufacturing plants would be located in the US. The reshoring initiative
supports this decision. The reshoring initiative works to bring manufacturing back to the US
from overseas [63]. This initiative helps with strengthening the U.S. economy as it balances the
trade and budget deficits, reduces unemployment by creating good and well-paying
manufacturing jobs, and fosters a skilled workforce. The benefits of reshoring to the
manufacturing companies include reducing the total cost of their products, improving their
balance sheets, and increasing effectiveness for product innovations. These benefits are achieved
by using the different resources provided by the Reshoring Initiative, such as the total cost of
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ownership estimator, case studies, reshoring library, webinars, news items and presentations
[63].
Reshoring also helps companies avoid problems due to international currency
fluctuations, tariffs, and logistics. With reshoring, manufacturing plants can better protect trade
secrets and patents. There is an abundant supply of natural gas in the US that can keep operating
costs reasonable. Local and state governments give tax incentives and enterprise zones to
incentivize companies to build manufacturing plants in their state or locality. Additionally, labor
costs in China are increasing, while US labor costs have remained flat over a decade [4]. Costs of
managing remote suppliers and production facilities can be high and managerial requirements of
a global business are significant. The cost of an elongated supply chain is high [4]. Hidden costs
can arise in typical low-cost manufacturing countries due to corruption. Some examples of
corruption are illegal payments, deliberately omitting quality processes, and theft of intellectual
property [4].
Within the US, we decided to build the plant in New Jersey. In New Jersey, there is a
2.1% tax rate for a new facility and a 5% tax rate for a new facility, which is lower as compared
to that in other states. There are 230 establishments in pharmaceutical preparation manufacturing
facilities, and the number of these facilities grew by 26.8% from 2014 to 2019 [40]. A majority
of life sciences industry related establishments can be found along major highways in New
Jersey within a close proximity to New York, New York [40]. New Jersey is close to consumer
markets both within and outside the US. It is a global transportation hub as it is home to the Port
of New York and New Jersey, has good rail connectivity, and many international destinations
can be reached by daily nonstop flights at airports [48]. A business located in central New Jersey
can serve more than 38 million consumers within a two-hour drive and can reach 33% of the
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United States population within a day’s drive from any location in New Jersey [48]. New Jersey
also has a highly educated workforce. 40% of New Jersey’s workforce graduates from college
with a bachelor’s degree or higher, while the national average is 32% [48].

Section 20.2 Environmental and Social Implications
During both manufacturing processes, powders are involved, and dust can be produced
during different operations in the processes. Dust produced during manufacturing is a health
hazard as an excess of the fine particulate matter in air can lead to a dust explosion. Therefore,
all dust in both manufacturing facilities will have to be contained. The pieces of equipment that
were selected for both processes ensure that all the dust is contained. Additionally, the
appropriate personal protective equipment (PPE) will be provided to the operators to protect
them while they are working in the facilities.
The batch and continuous processes generate exhaust air and evaporated water during the
granulation and drying and also during tablet coating. These are not harmful to the environment.
Additionally, both processes use a substantial amount of utilities, including processing water,
steam, and electricity, and this contributes to high energy and water usage demands. The
continuous process has slightly higher electricity demand than the batch processes, while the
batch process has a higher steam and water demand than the continuous process, as shown in
Section 19.2.2.
Continuous processes can be more efficiently scaled up. The throughput can be increased
without having to change the equipment being used. Additionally, experiments can be set up
more quickly for a continuous process compared to those for a batch process [34]. This is
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important in case of a public health emergency, as a continuous process can be used to rapidly
scale up production to meet increased demand for a drug.

Section 20.3 Shipping
To make sure that there is enough inventory to keep the facilities running in case of
emergencies, shipments of 13.5 tonnes (or 28 super sacks) of excipients will be received twice a
month. As the API is transferred within the company in the US, 13.5 tonnes of the API will be
delivered via truck twice a month. The excipients, which will be shipped from outside the US,
will arrive in super sacks loaded in a shipping container. A shipping container is 40 ft long, 8 ft
wide, and 8.5 ft tall, and each super sack is 35 inches long, 35 inches wide, and 48 inches tall. A
truckload is assumed to hold the same number of super sacks as a shipping container. For a bulk
density of 0.5 kg/L, 28 super sacks of API and excipients would be needed in each shipment in a
month to meet the tablet production targets. The bulk density is used to find the volume occupied
by 13.5 tonnes of API, which is subsequently used to calculate the number of super sacks needed
to hold that volume of API. Similar calculations are done for the excipients. Therefore, a
truckload of API and a shipping container of excipients would contain 28 super sacks each.
Pallets with an area of 36 inches square are used for support under each super sack. Thus, 28
pallets each are present for the super sacks in the truckloads of API and in the shipments of
excipients to be received twice a month. Based on a recommendation from Professor Vrana, the
average inventory for each facility would include two shipments of API and excipients—one
shipment in the warehouse, and one en route to the facility.
The product is sent for packaging via trucks once a month. After tablet coating, the
tablets will be stored in the Rhino BV-60 bins discussed in Section 17.1. These bins have a
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volume of 90 ft3. Therefore, the number of bins needed to store the tablets produced in a month
was calculated to be 42. The average product inventory will be 1.5 truckloads, with one
truckload having the same dimensions as the shipping container discussed earlier. One truckload
will be able to hold 30 bins. Thus, 1.5 truckloads are needed every month to send the tablets to
the packaging facility.
Table 20.3.1 Information for shipping raw materials and products
For shipping of raw materials:
Volume of a shipping container

2720 ft3

Volume of a super sack

34 ft3

Mass of API in each shipment in a month

13.5 tonnes

Mass of excipients in each shipment in a month

13.5 tonnes

Number of super sacks containing API in each shipment in a month

28 super sacks

Number of super sacks containing API in each shipment in a month

28 super sacks

Total number of super sacks in one shipment

56 super sacks

Total number of pallets in one shipment

56 pallets

For shipping of product:
Mass of tablets made in one month

54.2 tonnes

Volume of one bin

90 ft3

Number of bins needed to ship the tablets to a packaging facility

42 bins
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Section 20.4 Cleaning
Cleaning the equipment for both processes is necessary to maintain product quality and
output. Time would be taken away from manufacturing for cleaning the equipment in the
continuous process. A reasonable run length for the continuous process before it is shut down for
cleaning was determined by a sensitivity analysis. This run length will be used by the process
R&D team to further optimize the process and select a suitable cleaning reagent. The process run
length had to be long enough to ensure that the plant would produce a sufficient number of
tablets to be profitable while also maintaining the quality of those tablets. Increasing the process
run length increases profits but carries the risk of reducing product output and quality due to
infrequent cleaning. Therefore, a process run length that maintained both profits and quality was
estimated using a sensitivity analysis.
Based on a recommendation from our project author, it was assumed that one round of
cleaning would require 16 hours—4 hours for shutting down the process and disassembling the
equipment, 8 hours for cleaning the disassembled equipment, and 4 hours for reassembling the
equipment and starting up the process. For different process run lengths, the number of rounds of
cleaning and subsequently the total revenue lost because of the time spent in cleaning instead of
producing tablets was calculated. The revenue from each tablet was $0.01. It was found that
changing the process length from one week to four weeks led to a substantial percentage increase
in profits. However, increasing the process length above four weeks did not significantly
increase profits. Therefore, a reasonable target run length for both processes to be used by the
process R&D team was determined to be four weeks. Detailed calculations for the sensitivity
analysis are in Section 25.5.
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It should be noted that increasing the process run length could also increase costs of
cleaning as greater buildup of residue in the equipment could warrant the use of larger amounts
of the cleaning reagent. However, this is to be calculated and optimized by the process R&D
team and is out of scope for this report.
For the batch process, the equipment will be cleaned after every campaign of 8 batches.
The costs of using clean-in-place and steam-in-place operations for cleaning all the equipment
except the tablet press were calculated. The tablet press cannot be cleaned by steam-in-place and
clean-in-place operations as it runs semi-continuously. The calculated costs were low as
compared to other process costs, such as the costs of equipment and utilities, and so they were
neglected in the profitability analysis. Calculations for the cost of cleaning for the batch process
are included in the Section 25.5.
Table 20.4.1 Table showing the impact on profits when process run length is increased
Change in process run length

Percentage increase in profits

From 1 week to 4 weeks

8%

From 4 weeks to 8 weeks

1.2%

From 4 weeks to 10 weeks

1.5%
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Section 21: Profitability Analysis—Business Case
Section 21.1 Cash Flow Model
Beginning in 2022, the plant will be designed for 1 year, constructed for 1 year and
produce tablets for 21 years. The plant is assumed to operate at 90% of the total capacity for all
years. For this part of the analysis, a cost of $0.01/tablet is used, and this will be evaluated in
Section 21.3. As described in Section 18, the total capital investment is $31.6 million and $24.2
million for the batch and continuous process respectively. A tax rate of 23% was used as the
plants will be built in the US. The full cash flow model and for both processes and equations
used to calculate cash flow can be found in Section 25.8. Table 21.1.1 and Table 21.1.2 show a
summary of cash flow for the batch and continuous process respectively. The cumulative net
present value at an interest rate of 15% shows that the manufacturing plant will have more cash
leaving than entering. This can be seen in Table 21.1.1 and Table 21.1.2 as the cumulative net
present is negative up until 2044 for both processes. Overall, the net present value (NPV) in 2044
totals to ($17,605,300) and ($6,725,800) for the batch and continuous processes respectively. As
the cumulative NPV in 2044 for the continuous process is less negative than that for the batch
process, it can be concluded that the continuous process would be more profitable.
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Table 21.1.1 Summary of Cash Flow for Batch Process ($0.01/tablet). For the unabridged cash
flow table, see Table 25.8.1.

Year
number
0
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22

Year
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
2032
2033
2034
2035
2036
2037
2038
2039
2040
2041
2042
2043
2044

Percentage of
Design Capacity
($)
0%
0%
90%
90%
90%
90%
90%
90%
90%
90%
90%
90%
90%
90%
90%
90%
90%
90%
90%
90%
90%
90%
90%

Cash Flow ($)
(31,621,900)
2,325,200
3,022,900
2,278,700
1,832,200
1,832,200
1,497,300
1,162,400
1,162,400
1,162,400
1,162,400
1,162,400
1,162,400
1,162,400
1,162,400
1,162,400
1,162,400
1,162,400
1,162,400
1,162,400
1,162,400
1,641,800

Cumulative Net
Present Value at
15% ($)
(27,497,300)
(25,739,100)
(23,751,500)
(22,448,600)
(21,537,700)
(20,745,600)
(20,182,700)
(19,802,700)
(19,472,300)
(19,184,900)
(18,935,100)
(18,717,800)
(18,528,900)
(18,364,600)
(18,221,800)
(18,097,500)
(17,989,500)
(17,895,600)
(17,813,900)
(17,742,900)
(17,681,100)
(17,605,300)

168

Table 21.1.2 Summary of Cash Flow for Continuous Process ($0.01/tablet). For the unabridged
cash flow table, see Table 25.8.2.

Year number

Year

Percentage of
Design Capacity ($)

0
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22

2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
2032
2033
2034
2035
2036
2037
2038
2039
2040
2041
2042
2043
2044

0%
0%
90%
90%
90%
90%
90%
90%
90%
90%
90%
90%
90%
90%
90%
90%
90%
90%
90%
90%
90%
90%
90%

Cash Flow ($)

Cumulative Net
Present Value at
15% ($)

(24,268,400)
3,020,500
3,555,800
2,984,800
2,642,200
2,642,200
2,385,300
2,128,400
2,128,400
2,128,400
2,128,400
2,128,400
2,128,400
2,128,400
2,128,400
2,128,400
2,128,400
2,128,400
2,128,400
2,128,400
2,128,400
2,503,100

(21,103,000)
(18,819,100)
(16,481,100)
(14,774,500)
(13,460,800)
(12,318,500)
(11,421,800)
(10,726,000)
(10,121,000)
(9,594,900)
(9,137,500)
(8,739,600)
(8,393,700)
(8,092,900)
(7,831,400)
(7,603,900)
(7,406,100)
(7,234,200)
(7,084,600)
(6,954,600)
(6,841,500)
(6,725,800)

Section 21.2 Profitability Measures
As mentioned in Section 21.1, this economic analysis is only conducted for 21 years of
production with a tablet selling price of $0.01/tablet. Additionally, using guidelines from Seider
et al [51], an inflation rate of 2% is used throughout the analysis. Table 21.2.1 summarizes the
profitability measures achieved by this economic analysis for both processes. The IRR was found
by setting the NPV to zero for both processes. The equations used to calculate ROI can be found
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in Section 25.9. The batch process was not profitable for a selling price of $0.01/tablets, with an
ROI of -2.39% and IRR of -0.30%. The continuous process was more profitable for the same
selling price, with an ROI of 2.71% and IRR of 8.44%.
Table 21.2.1 Profitability Measures for Batch and Continuous ($0.01/tablets)
Batch
Internal Rate of Return (IRR)
Net Present Value of Project in
2044 ($)

-0.30%

Continuous
8.44%

(17,605.300)

(6,725,800)

9,135,720

8,997,300

(7,626,070)

(6,223,192)

(2,491,403)

(1,911,494)

225,803

(196,101)

(755,950)

656,512

31,621,904
-2.39%

24,268,428
2.71%

ROI Analysis (Third Production
Year)
Annual Sales ($)
Annual Costs (S)
Depreciation ($)
Income Tax ($)
Net Earnings ($)
Total Capital Investment ($)
ROI

Section 21.3 Sensitivity Analysis—Selling Price of Tablets
Section 21.2 shows that at $0.01/tablet, both the manufacturing plants would not be very
profitable, especially the batch process. Table 21.3.1 and Table 21.3.2 show that increasing the
selling price of the tablets from $0.01/tablet to $0.02/tablet would make both processes more
profitable. Also, for a selling price of $0.02/tablet, the batch process would no longer have a
negative IRR and ROI. For the batch process, Table 21.3.1 shows that increasing selling price
from $0.01/tablet to $0.02/tablet will increases the IRR from -0.30% to 25.80% and increase the
ROI from -2.39% and 17.29%. For the continuous process, Table 21.3.2 shows that increasing
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selling price from $0.01/tablet to $0.02/tablet will increases the IRR from 8.44% to 37.10% and
increase the ROI from 2.71% and 27.97% for the continuous process. It can be concluded that
selling tablets at $0.01/tablets would not be profitable for both processes, particularly the batch
process.
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Table 21.3.1 Profitability Measures for Batch Process at Different Selling Prices

Internal Rate of Return (IRR)
Net Present Value of Project in 2044 ($)

$0.01/tablet
-0.30%

$0.02/tablet
25.80%

$0.03/tablet
46.39%

(17,605.300)

16,548,000

50,701,300

9,135,720

18,271,440

27,407,160

(7,626,070)

(8,681,246)

(9,736,421)

(2,491,403)

(2,491,403)

(2,491,403)

225,803

(1,632,722)

(3,491,247)

(755,950)

5,466,070

11,688,089

31,621,904
-2.39%

31,621,904
17.29%

31,621,904
36.96%

ROI Analysis (Third Production Year)
Annual Sales ($)
Annual Costs (S)
Depreciation ($)
Income Tax ($)
Net Earnings ($)
Total Capital Investment ($)
ROI
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Table 21.3.2 Profitability Measures for Continuous Process at Different Selling Prices
$0.01/tablet
Internal Rate of Return (IRR)

$0.02/tablet

$0.03/tablet

8.44%

37.10%

62.95%

(6,725,800)

26,931,800

60.567,600

8,997,300

18,000,450

26,997,750

(6,223,192)

(7,273,056)

(8,312,244)

(1,911,494)

(1,911,494)

(1,911,494)

(196,101)

(2,027,657)

(3,858,023)

656,512

6,788,243

12,915,989

24,268,428
2.71%

24,268,428
27.97%

24,268,428
53.22%

Net Present Value of Project in 2044 ($)

ROI Analysis (Third Production Year)
Annual Sales ($)
Annual Costs (S)
Depreciation ($)
Income Tax ($)
Net Earnings ($)
Total Capital Investment ($)
ROI
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Section 22: Conclusions and Recommendations
The goal of this project was to design a process to formulate a small molecule drug
product with an anticipates sales of 1 billion tablets per year, and a goal cost of conversion of
$0.01 per tablet through the evaluation of both a batch and a continuous process. The goal
conversion of $0.01 per tablet is ambitious in the pharmaceutical industry, as is reflected by the
results presented in this report. Through rigorous profitability analysis, it was found that at a cost
of conversion of $0.01 per tablet, the batch process is not profitable, and the continuous process
is marginally profitable. However, when the cost of conversion is increased to $0.02 per tablet,
the profitability of both processes increases significantly, as shown in Table 22.1.
Table 22.1. Rigorous Profitability Analysis Results
Cost of

$0.01

$0.02

Conversion
IRR

NPV

Batch

-0.30%

Continuous

8.44%

ROI

IRR

NPV

($17,605,300) -2.39%

25.80%

$16,548,000 17.29%

($6,725,800)

37.08%

$26,931,800 27.97%

2.71%

ROI

Based on these results, we recommend that pharmaceutical companies looking to mass
produce a small molecule drug product pursue a continuous manufacturing method. The
profitability analysis shows that while the continuous process may require higher utility costs,
the capital costs are significantly lower, and less operators are needed to run the continuous
facility, resulting in significantly greater profits as compared to traditional batch manufacturing.
We also recommend a cost of conversion greater than $0.01 per tablet to earn substantial profit.
Annual production of 1 billion tablets sold at $0.02 per tablet for a plant life of 21 years results in
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an IRR and ROI as high as 37% and 28% respectively for the continuous process. Regardless of
the cost of conversion, the company should implement the continuous manufacturing process to
maximize profits.
Continuous manufacturing of small molecule pharmaceuticals is a new process that
pharmaceutical companies have been slow to adapt, yet this report reflects the potential
economic implications of the adoption of this type of manufacturing in new pharmaceutical
production plants. Lower production costs will allow for a higher volume of production, lower
product prices, and therefore increased public accessibility to drugs necessary to maintain high
standards of public health.
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Section 25: Appendix
Section 25.1. Problem Statement
Formulation of a High-Volume Small Molecule Drug Product
Background
Most small molecule Active Pharmaceutical Ingredients, API’s, are formulated into
tablets in large batches on the order of millions of tablets or more. The Critical Quality
Attributes, CQA’s, are typically the assay of the API and dissolution measured in vitro as well
tablet properties such as weight, thickness, hardness and appearance. A typical process to
formulate the API would include some type of granulation of the API, blending of the granules
with other solids, compression of the blend into tablets, and application of a coating to give the
tablets the required appearance. Recently continuous manufacturing of tablets has become more
and more popular in the pharmaceutical industry due to advantages inherent to continuous
manufacturing for high-volume products. In both cases, batch and continuous manufacturing,
modern facilities are typically built with a good deal of automation so that paper batch records
are not required, and data is automatically gathered electronically.
Project Statement
You will be working on a project where you must design a process to formulate
Clairatenol a blockbuster drug product with anticipated sales of 1 billion tablets per year, and
design the production facility in which it will be manufactured. You should evaluate both batch
and continuous manufacturing and target a cost for conversion into tablets of 1 cent per tablet.
The granulation step can be run in a high shear granulator in the case of batch production or in a
twin-screw granulator in the case of continuous manufacturing. The blending step can be run in
a bin blender in the case of batch production and in a continuous blender in the case of
continuous manufacturing. In both cases the tablet press will be the same or similar. The tablet
is coated but a reliable continuous tablet coater may not be commercially available so unless one
is recommended by the project team, the coating can be done in a “semi-batch” mode in the case
of continuous production. Semi-batch coaters for continuous manufacturing of tablets are
typically smaller coaters where the cycle time of the coating batch is matched with the
throughput of the continuous line such that it is always in use (including charging and
discharging).
Once you have designed the process, you will need to design the manufacturing facility,
keeping in mind the differences in the size of the equipment and how that will impact the
footprint of the facility. As you design the facility, you should do your best to keep capital costs
of the equipment and operating costs of the facility to a minimum. You can build the plant
anywhere in the world, but you should consider things like cost of labor and availability of
dependable supplies of utilities such as electricity and water when you choose the location. The
facility should be designed so that the operators are safe from hazards like inhaling dust from the
powders, no waste is released to the environment, and any risks of dust explosions are accounted
for in the design. The final design should compare a batch and a continuous process, ultimately
making a recommendation as to which is a wiser investment.
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Figure 25.2.1 SuperPro Flowsheet for the batch process.

25.2.1 SuperPro for the Batch Process
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Figure 25.2.2. SuperPro report of overall process data for the batch process.
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Figure 25.2.3. First part of SuperPro stream report for the batch process. This report was
used to double check material balance calculations. Excipients were modeled as
“carbohydrates” in the SuperPro software.
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Figure 25.2.4. Continuation of SuperPro stream summary for the batch process.
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Figure 25.2.5. Continuation of SuperPro stream summary for the batch process.
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Figure 25.2.6 SuperPro Flowsheet for the continuous process.

Section 25.2.4 SuperPro Flowsheet and Material Balances for the Continuous Process
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Figure 26.2.7. SuperPro overall process data for the continuous process
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Figure 25.2.8. First part of SuperPro stream report for the continuous process. This report was
used to double check material balance calculations. Excipients were modeled as “carbohydrates”
in the SuperPro software.
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Figure 25.2.9. Continuation of SuperPro stream summary for the continuous process.
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Section 25.3 Energy Balance Calculations
25.3.1 Energy Balance Calculations for Granulation
The mechanical work required for both fluid bed and twin-screw granulation is assumed to be
equal to the motor power of the heat exchangers, pumps, blowers, and vessels. Thus, work is
omitted from energy balance calculations and the resulting heat balances are reported below.
For fluid bed granulation:
𝑇

𝑚𝑤𝑎𝑡𝑒𝑟,𝑣𝑎𝑝 =

𝑇

𝑓
(∅𝑠𝑎𝑡
− ∅𝑖 𝑖 ) ∗ 𝑚̇𝑎𝑖𝑟 ∗ 𝑡
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(Eqn. 25.3.1)

𝑄𝑎𝑖𝑟 = 𝑚𝑔𝑟𝑎𝑛 𝐶𝑝,𝑔𝑟𝑎𝑛 𝛥𝑇𝑔𝑟𝑎𝑛 + 𝑚𝑤𝑎𝑡𝑒𝑟 𝐶𝑝,𝑤𝑎𝑡𝑒𝑟 𝛥𝑇𝑤𝑎𝑡𝑒𝑟 + 𝑚𝑤𝑎𝑡𝑒𝑟,𝑣𝑎𝑝 𝛥𝐻𝑣𝑎𝑝,𝑤𝑎𝑡𝑒𝑟
(Eqn. 25.3.2)
𝑄𝑎𝑖𝑟 = 𝑚̇𝑎𝑖𝑟 𝐶𝑝,𝑎𝑖𝑟 𝛥𝑇𝑎𝑖𝑟 = 𝜌𝑣̇̇ 𝑎𝑖𝑟 𝐶𝑝,𝑎𝑖𝑟 𝛥𝑇𝑎𝑖𝑟
(Eqn. 25.3.3)
𝑄𝑠𝑡𝑒𝑎𝑚 = 𝑄𝑎𝑖𝑟
(Eqn. 25.3.4)
𝑄𝑠𝑡𝑒𝑎𝑚 = 𝑚̇𝑠𝑡𝑒𝑎𝑚 ℎ𝑓𝑔
(Eqn. 25.3.5)

Steam requirement calculations were conducted using equations 25.3.3 to 25.3.5 above.
The amount of water evaporated during granulation is calculated using equation 25.3.1, where
𝑇

𝑇

𝑓
∅𝑠𝑎𝑡
is the absolute humidity the saturated exhaust air, ∅𝑖 𝑖 is the inlet absolute humidity (both

are measured in g water/kg air), and t is time. An important assumption made for these
calculations is that the pressure increase from the blower was small enough such that air
properties are taken to be at ambient conditions. Equations 25.3.1 to 25.3.5 are not relevant for
continuous twin-screw granulation as there is no hot air input to that process.
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Centrifugal blowers are required to increase the velocity of air upstream of each of the
heat exchangers. Blower motor power is a function of volumetric flow rate and pressure increase
across the blower. The following correlations from Seider et al., were used to determine blower
motor power.
𝑘

𝑘

𝑃𝐵 = 0.00436 (𝑘−1)

𝑄1 𝑃1

𝑃𝑂 𝑘−1
[(
)
𝜂𝐵
𝑃1

− 1]
(Eqn. 25.3.6)

𝑃𝐶 =

𝑃𝐵
𝜂𝑀

(Eqn. 25.3.7)
Where 𝑃𝐵 is the brake horsepower, k is a constant specific heat ratio, Q1 is the volumetric
flow rate, P1 is outlet pressure, P0 is inlet pressure, ηB is blower efficiency, ηM is blower motor
efficiency, and PC is power consumption by the blower motor.

25.3.2 Energy Balances for Fluid Bed Drying
The mechanical work required for both continuous and batch fluid bed drying is assumed to be
equal to the motor power of the heat exchangers, pumps, blowers, and vessels. Thus, work is
omitted from energy balance calculations and the resulting heat balances are reported below.
Equations 25.3.3 to 25.3.5 hold for fluid bed drying. While fluid bed granulation operates at
ambient, saturated conditions, fluid bed drying operates at 40ºC. For the batch process, there is
idle time between each equipment use and the energy required to reheat the vessel for each batch
must be considered. Therefore, for batch fluid bed drying, equation 25.3.2 is modified to
equation 25.3.8 below.
𝑄𝑎𝑖𝑟 = 𝑚𝑔𝑟𝑎𝑛 𝐶𝑝,𝑔𝑟𝑎𝑛 𝛥𝑇𝑔𝑟𝑎𝑛 + 𝑚𝑤𝑎𝑡𝑒𝑟 𝐶𝑝,𝑤𝑎𝑡𝑒𝑟 𝛥𝑇𝑤𝑎𝑡𝑒𝑟 + 𝑚𝑣𝑒𝑠𝑠𝑒𝑙 𝐶𝑝,𝑣𝑒𝑠𝑠𝑒𝑙 𝛥𝑇𝑣𝑒𝑠𝑠𝑒𝑙
+ 𝑚𝑤𝑎𝑡𝑒𝑟 𝛥𝐻𝑣𝑎𝑝,𝑤𝑎𝑡𝑒𝑟
(Eqn. 25.3.8)
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Exhaust air humidity is calculated using equation 25.3.9.
𝑇

∅𝑓2 =

(𝑚𝑤𝑎𝑡𝑒𝑟,𝑡𝑜𝑡 − 𝑚𝑤𝑎𝑡𝑒𝑟,𝑔𝑟𝑎𝑛 )
𝑇
+ ∅𝑖 1
1000 ∗ 𝑚̇𝑎𝑖𝑟 ∗ 𝑡
(Eqn. 25.3.9)

The power required by the blowers is calculated using equations 25.3.6 and 25.3.7.
25.3.3 Energy balance calculations for milling in batch and continuous processes
Main energy balance equation: ∆𝐸 = 𝑄 − 𝑊
∆𝐻 + ∆𝐾𝐸 + ∆𝑃𝐸 = 𝑄 − 𝑊
(Eqn. 25.3.10)
Neglecting ∆PE because the distance between the mill inlet and outlet is small (~0.4 m for
Quadro FlexSift S20),
∆𝐻 + ∆𝐾𝐸 = 𝑄 − 𝑊
(Eqn. 25.3.11)
For calculating ∆H,
∆𝐻 = 𝑚 ∙ 𝐶𝑝 ∙ ∆𝑇
(Eqn. 25.3.12)
Both the API and excipients are assumed to have the same properties as water (Cp = 4.18 kJ/kg
K). All the data below was obtained from Quadro FlexSift S20 brochures and from speaking
with a Quadro sales representative.
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Table 25.3.1 Summary of mill energy balance calculations for the batch process
Parameters

Values

Temperature of inlet stream to mill

25°C

Temperature of outlet stream from mill

28°C

Duration of milling

3 hours

Inlet Stream

Outlet Stream

Mass of API

1000 kg (333 kg/hr)

Mass of excipients

560 kg (187 kg/hr)

Mass of API

1000 kg (333 kg/hr)

Mass of excipients

560 kg (187 kg/hr)

Mill rotational speed

700 RPM

Drive motor

3.73 kW

Friction factor

0.014

Shaft work (W)

-3.7 kW

∆H

1.8 kW

∆KE

0.004 kW

Heat released (Q)

-1.9 kW

Heat capacity of material going through mill

6520.8 kJ/K

Temperature rise in the material if all the heat released is

3°C

absorbed by the material
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For the mill used in the continuous process, the value for the drive motor is lower due to lower
throughput. A lower amount of energy is needed for milling the lower throughput to the mill for
the continuous process.
Table 25.3.2 Summary of mill energy balance calculations for the continuous process
Parameters

Values

Temperature of inlet stream to mill

25°C

Temperature of outlet stream from mill

28°C

Inlet Stream

Mass of API

41 kg/hr

Mass of excipients

23 kg/hr

Mass of API

41 kg/hr

Mass of excipients

23 kg/hr

Outlet Stream

Mill rotational speed

700 RPM

Drive motor

0.55 kW

Friction factor

0.014 [49]

Shaft work (W)

-0.54 kW

∆H

0.22 kW

∆KE

0.0005 kW

Heat released (Q)

-0.32 kW

Heat capacity of material going through mill (for the material

269 kJ/K

going through the mill in one hour)
Temperature rise in the material if all the heat released is

4°C

absorbed by the material
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25.3.4 Energy balance calculations for blending in batch and continuous processes
Main energy balance equation: ∆𝐸 = 𝑄 − 𝑊
∆𝐻 + ∆𝐾𝐸 + ∆𝑃𝐸 = 𝑄 − 𝑊
(Eqn. 25.3.13)
∆PE = 0 for the bin blender because blender rotation causes the powder to rise and fall back
down repeatedly.

∆PE = 0 for the continuous blender because the continuous process is a horizontal manufacturing
line (solids flow is handled in a horizontal manner) and the continuous blender (which is
cylindrical in shape) is positioned such that its axis is parallel to the ground.
∆𝐻 + ∆𝐾𝐸 = 𝑄 − 𝑊
(Eqn. 25.3.14)
For calculating ∆H,
∆𝐻 = 𝑚 ∙ 𝐶𝑝 ∙ ∆𝑇
(Eqn. 25.3.15)

Both the API and excipients are assumed to have the same properties as water (Cp = 4.18 kJ/kg
K). All the data below was obtained from LB Bohle PM-6000 brochures and from speaking with
an LB Bohle sales representative.
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Table 25.3.3 Summary of blending energy balance calculations for the batch process
Parameters

Values for pre-blender

Values for blender

Temperature of inlet stream 1 to blender

22°C

28°C

Temperature of inlet stream 2 to blender

22°C

25°C

Temperature of outlet stream from blender

25°C

30°C

Duration of blending

40 minutes

40 minutes

Mass of API

1000 kg

1000 kg

Mass of excipients

0

560 kg

Mass of API

0

0

Mass of excipients

520 kg

360 kg

Mass of API

1000 kg

1000 kg

Mass of excipients

520 kg

920 kg

Blender rotational speed

5 RPM

5 RPM

Drive motor

25.5 kW

25.5 kW

Shaft work (W)

-61,200 kJ

-61,200 kJ

∆H

19,060 kJ

20,566 kJ

∆KE

0.23 kJ

0.3 kJ

Heat released (Q)

-42,140 kJ

-40,634 kJ

Inlet Stream 1

Inlet Stream 2

Outlet Stream
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Heat capacity of material going through

6354 kJ/K

8025.6 kJ/K

6.6°C

5°C

blender
Temperature rise in the material if all the heat
released is absorbed by the material
The blender rotational speed is higher for the continuous blender because of its lower
throughput. A higher rotational speed is needed to homogenize the mixture when the amount of
material present in the blender at any given moment is relatively small [8].
All the data below was obtained from Gericke GCM-450 brochures and from speaking
with the head of Continuous Manufacturing at Gericke.
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Table 25.3.4 Summary of blending energy balance calculations for the continuous process
Parameters

Values for pre-blender Values for blender

Temperature of inlet stream 1 to blender

22°C

28°C

Temperature of inlet stream 2 to blender

22°C

25°C

Temperature of outlet stream from blender

25°C

30°C

Inlet Stream 1

Mass of API

41 kg/hr

41 kg/hr

Mass of excipients

0

23 kg/hr

Mass of API

0

0

Mass of excipients

21 kg/hr

15 kg/hr

Mass of API

41 kg/hr

41 kg/hr

Mass of excipients

21 kg/hr

38 kg/hr

Blender rotational speed

25 RPM

25 RPM

Drive motor

0.37 kW

0.37 kW

Shaft work (W)

-0.37 kW

-0.37 kW

∆H

0.22 kW

0.24 kW

∆KE

1.1E-7 kW

1.5E-7 kW

Heat released (Q)

-0.15 kW

-0.13 kW

Inlet Stream 2

Outlet Stream
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Heat capacity of material going through

261 kJ/K

331 kJ/K

2°C

1.5°C

blender (for the material going through the
blender in one hour)
Temperature rise in the material if all the
heat released is absorbed by the material
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25.3.5 Energy Balance for Rotary Tablet Press.
The work done by and the energy of the rotary tablet press can be found using the following
equations.
∆𝐸 = 𝑊 − 𝑄
(Eqn. 25.3.16)
𝑄 = 𝑚 × 𝐶𝑃 × ∆𝑇
(Eqn. 25.3.17)
𝑊𝐶𝑜𝑚𝑝𝑟𝑒𝑠𝑠𝑖𝑜𝑛 𝑓𝑜𝑟𝑐𝑒 = 𝐹𝑐𝑜𝑚𝑝𝑟𝑒𝑠𝑠𝑖𝑜𝑛 × 𝑣𝑡𝑢𝑟𝑟𝑒𝑡
(Eqn. 25.3.18)
All the information used for these calculations were found on GEA’s website for the MODUL™
P Tablet Press (GEA). One exception is the turret speed, which was provided by speaking to a
vendor. Tables 25.3.5 and Table 25.3.6 represent the summary of the energy balance calculations
for the batch and continuous processes respectively. The main difference between the two
processes is that tablet heat gain because the feed rate for the tablet press is more for the batch
process than the continuous process.
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Table 25.3.5 Summary of Tablet Press for Batch Process Energy Balance Calculations
Parameters

Values

Inlet Temperature (°C)

30

Outlet Temperature(°C)

32

Temperature change (°C)

2

Heat Capacity (J/g°C)

4200

Turret speed (rpm)

50

Turret speed (m/s)

5.24

Main compression force (kN)

80

Tablet heat gain (kW)

213

Work done by compression force (kW)

419

Energy of tablet press (kW)

206
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Table 25.3.6 Summary of Tablet Press for Continuous Process Energy Balance Calculations
Parameters

Values

Inlet Temperature (°C)

30

Outlet Temperature(°C)

32

Temperature change (°C)

2

Heat Capacity (J/g°C)

4200

Turret speed (rpm)

50

Turret speed (m/s)

5.24

Main compression force (kN)

80

Tablet heat gain (kW)

184

Work done by compression force (kW)

419

Energy of tablet press (kW)
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25.3.6 Energy Balance for Batch and Continuous Tablet Coater
A thermodynamic model of the tablet coating system will allow us to determine the heat
loss of the system by taking into account the enthalpy change of the processing air, and the
enthalpy change of the coating. For this calculation, we are assuming that 90% of the coating
solution is water and all that water is evaporated during drying. The following equations are used
to develop the thermodynamic model for the batch and continuous systems.
∆𝐻 = ∆𝐻𝑎𝑖𝑟 +∆𝐻𝑐𝑜𝑎𝑡 +∆𝐻𝑡𝑎𝑏𝑙𝑒𝑡 + ∆𝐻𝑙𝑜𝑠𝑠 =0
(Eqn. 25.3.19)
∆𝐻𝑎𝑖𝑟 = 𝑚𝑎𝑖𝑟,𝑖𝑛 𝐶𝑝,𝑎𝑖𝑟 (𝑇𝑎𝑖𝑟,𝑜𝑢𝑡 − 𝑇𝑎𝑖𝑟,𝑖𝑛 )
(Eqn. 25.3.20)
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∆𝐻𝑐𝑜𝑎𝑡 = 𝑥𝑤 𝑚𝑐𝑜𝑎𝑡 𝐶𝑝,𝑤 (𝑇𝑎𝑖𝑟,𝑜𝑢𝑡 − 𝑇𝑐𝑜𝑎𝑡 )+ 𝑥𝑤 𝑚𝑐𝑜𝑎𝑡 ∆𝐻𝑣,𝑤 +
𝑥𝑜𝑟𝑔 𝑚𝑐𝑜𝑎𝑡 𝐶𝑝,𝑜𝑟𝑔 (𝑇𝑎𝑖𝑟,𝑜𝑢𝑡 − 𝑇𝑐𝑜𝑎𝑡 )+ 𝑚𝑐𝑜𝑎𝑡 ∆𝐻𝑣,𝑜𝑟𝑔
≈ 𝑚𝑐𝑜𝑎𝑡𝑖𝑛𝑔 𝐶𝑝,𝑤 (𝑇𝑎𝑖𝑟,𝑜𝑢𝑡 − 𝑇𝑐𝑜𝑎𝑡 )+ 𝑚𝑤 ∆𝐻𝑣,𝑤
(Eqn. 25.3.21)
The temperatures for the different streams going in and out of the batch tablet press were
found using the Suteric Aqueous Enteric Coating System Technical Data Sheet, that can be found
in Section 15.10.9. The temperatures for the different streams going in and out of the continuous
tablet press were obtained using the Continuous Coater Publication sent by a Thomas
Engineering representative and can be found in Section 25.10.11 [33]. Additionally, for these
thermodynamic models, it was assumed that the tablet has a 15 mm diameter and 5 mm
thickness, similarly to Tylenol (acetaminophen) tablet [18].
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Table 25.3.7 Summary of Batch Tablet Coater Energy Balance Calculations
Parameters
Inlet Load (kg)
Inlet coating (kg)
Inlet coating solution (kg)
Inlet Water (kg)
Max Process air volume (m3/h)

Values
1920
80
800
720
17858

Inlet tablet temperature (°C)

32

Inlet coating solution temperature (°C)

25

Inlet air Temperature (°C)
Exhaust Temperature (°C)
Product Temperature (°C)
Tablet output (kg)
Tablet Diameter(mm)
Tablet thickness(mm)
Tablet volume(mm3)

75
45
45
2000
15
5
884

Tablet Surface area (mm2)

589

Air heat capacity (J/kg°C)
Air density (J/kg°C)

700
1.2

Tablet heat capacity (water)
Coating heat capacity (J/g°C

4200
4200

Enthalpy of vaporization (kJ/kg)
Run time (hr)
Coating heat (MJ)

2260
6
8,347

Atomizing air heat (MJ)
Heat loss of coater (MJ)

-2700
5,647
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Table 25.3.8 Summary of Continuous Tablet Coater Energy Balance Calculations
Parameters
Inlet Load (kg/hr)
Inlet coating (kg/hr)
Inlet coating solution (kg/hr)
Inlet Water (kg/hr)
Process air volume (m3/h)

Values
78.8
3.28
32.83
29.55
6800

Inlet tablet temperature (°C)

32

Inlet coating solution temperature (°C)
Inlet air Temperature (°C)
Exhaust Temperature (°C)
Product Temperature (°C)
Total tablet throughput rate (kg/hr)

25
57
39
39
82

Tablet Diameter(mm)
Tablet thickness(mm)
Tablet volume(mm3)

15
5
884

Tablet Surface area (mm2)

589

Air heat capacity (J/kg°C)
Air density (kg/m3)
Tablet heat capacity (J/g°C)
Coating heat capacity (J/g°C)

700
1.2
4200
4200

Enthalpy of vaporization (kJ/kg)

2260

Coating heat (kW)
Atomizing air heat (kW)
Heat loss of coater (kW)

72
-29
44

The calculations for the utilities for the pumps, heat exchangers and blowers can be found
in Section 25.3.1 and Section 25.4.
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Section 25.4 Equipment Design
All the equations noted in this section were pulled from the Product and Process Design
Principles textbook (Seider et al). Details regarding the design of the heat exchangers and
blowers used in this system are detailed below.
25.4.1 Heat Exchanger Design
Section 15 details the logic behind the selected air volumetric flow rates, temperatures,
and humidity. The air is heated to its determined temperature in a heat exchanger using
condensed steam at 3.4 atm. Heat exchangers are used to heat the air that flows into the fluid bed
granulator and dryer, the continuous fluid bed dryer, and both the batch and continuous coater.
Countercurrent shell-and-tube heat exchangers were chosen. Once the heat duty of the heat
exchanger was determined as shown in Section 25.3.1 (𝑄̇𝑠𝑡𝑒𝑎𝑚 = 𝑄̇𝑎𝑖𝑟 = 𝑄̇ ), heat exchanger
design was performed using the following equations.

∆𝑇𝑙𝑚 =

𝐴=

∆𝑇1 − ∆𝑇2
∆𝑇
𝑙𝑛 ∆𝑇1
2

𝑄̇
𝑈 ∗ ∆𝑇𝑙𝑚 ∗ 𝐹𝑇

(25.4.1)

(25.4.2)

𝐹𝑇 was assumed to be 1 for each of the heat exchangers. Approximate values of the overall heat
transfer coefficient U were found within Seider, et al, and used to calculate the area manually.
Additionally, stream specifications were plugged into Aspen Plus to approximate the overall heat
transfer coefficient and area necessary for each of the designs. Design specifications were set
manipulate the flow rate of steam necessary to reach a specific outlet air temperature through
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condensation of the steam. Values for the required steam flow were compared and found to be
within 15% error, and the manually calculated flow rates were taken to be accurate. The area and
overall heat transfer coefficient generated by Aspen were accepted as the correct design values.
Electricity requirements to run each of the heat exchangers were taken from Aspen Plus once
design was complete. Sample Aspen input and output files for the fluid bed dryer heat exchanger
are included below.
Although costing correlations for shell-and-tube heat exchangers are available in Seider,
et al., the costs of these pieces of equipment were included in vendor quotes for the granulator,
dryer, and coaters, and design was performed simply to accurately approximate utility
requirements.
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Example Aspen Files for HX-1(B) run at the fluid bed granulator settings:
Input Summary:
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216

Report File:

217

218

219

220

221

222

223

224

225

226
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Section 25.5 Cleaning Costs
The cost of cleaning for each process was taken to be negligible. The evidence for this
assumption is presented below.
Section 25.5.1 Cleaning Considerations for the Batch Process
It was reported from conversations with pharmaceutical batch manufacturing engineers
(Dr. Marchut) that the batch equipment should be cleaned after every eight batches. Time did not
have to be taken away from manufacturing to clean most of the equipment because of ample idle
time. The tablet press, however, operates semi-continuously and must be cleaned during the
annual downtime. Equipment is to be cleaned using Clean-in-Place (CIP) followed by Steam-inPlace (SIP) operations included in the equipment. The amount of process water needed for each
CIP and the amount of steam required for each SIP were taken from the SuperPro mode and are
reported in Table 25.5.2 below. Table 25.5.1 shows the cost of the water, steam, SIP waste, and
CIP waste for cost calculations. Costs of water and steam were sourced from Seider, et al., while
costs of SIP and CIP waste were taken as given in SuperPro.
Table 25.5.1 Cost of Cleaning Utilities and Waste Removal for the Batch Process
Water

$0.27/m3

Steam

$0.0132/kg

CIP Waste

$0.005/kg

SIP Waste

$0.001/kg
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Table 25.5.2 Cost of Cleaning for the Batch Process
Unit Operation

Water per CIP (kg)

Steam per SIP(kg)

Waste Treatment Cost

BD-1(C)

1495

100

$7.58

GR-1(C)/DR-1(C)

1495

244

$7.72

ML-1(C)

1495

6

$7.48

BD-2(C)

1495

126

$7.60

TP-1(C)

Semi-continuous operation

TC-1(C)

1495

357

Total

1495

832

Cost ($)

$2

$11

$7.83

$38.22

Total Cost per Clean

$50

Total Annual Cost

$2,000

The annual cost of $2,000 is low enough that it was taken as negligible in cost analysis
calculations.

25.5.2 Continuous Cleaning Considerations
Unlike the batch process, time would have to be taken away from manufacturing to clean
the equipment in the continuous process. Therefore, a reasonable process run length before the
process is shut down for cleaning had to be estimated. For different values of process run length,
the profit made from running the process was calculated. The percentage increase in profits when
process run length is increased was also calculated. Each cleaning round takes 16 hours. The
revenue from each tablet is $0.01. The revenue gained from running the process for a year with
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no interruptions is $11.1 million. The total revenue lost because of cleaning is based on the
number of tablets not made while the equipment was being cleaned. The percentage increase in
profits is calculated for an increase in run length from the previous value to the current value.
Table 25.5.3: Summary of calculations for determining process run length before cleaning
Process run
length before
first round of
cleaning
1 week

Number of
rounds of
cleaning in
one year
52

Total days of
cleaning in
one year
(days/year)
35

Total revenue
lost because of
cleaning ($/year)

Profits per
year
($/year)

Percentage
increase in
profits

1,053,000

10,007,000 —

2 weeks

26

17

527,000

10,534,000 5%

3 weeks

17

12

351,000

10,709,000 2%

4 weeks

13

9

263,000

10,797,000 0.8%

5 weeks

10

7

211,000

10,850,000 0.5%

6 weeks

8

6

176,000

10,885,000 0.3%

7 weeks

7

5

150,000

10,910,000 0.2%
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Section 25.6 Purchase Cost Calculations

The following sections highlight the correlations used to calculate the purchase cost of
equipment that can be found in the third column of Table 17.1.1 and Table 17.1.2.

25.6.1 Granulator

25.6.1.1 Batch Fluid Bed Granulation and Drying

For batch granulation and drying, the correlations for a vertical pressure vessel and spray
dryer respectively were used. This is a flawed assumption as the granulator is not a pressure
vessel. For this calculation, the weight of the granulator is needed, and it was assumed the
granulator would weigh 6500lbs. For the spray dryer, the size factor is evaporation rate, W
(lb/hr) with a range of 30 to 3,000 lb/hr. Additionally, stainless steel is assumed as the material
for the equipment, so the material factor FM was 2. The following equations were used to
determine the purchase cost of the fluid bed granulator.
𝐶𝑉,𝑔𝑟𝑎𝑛𝑢𝑙𝑎𝑡𝑜𝑟 = 𝑒𝑥𝑝(7.1390 + 0.18255 ln(𝑊) + 0.02297(ln(𝑊))2
(Eqn. 25.6.1)
𝐶𝑃,𝑔𝑟𝑎𝑛𝑢𝑙𝑎𝑡𝑜𝑟 = 𝐹𝑀 𝐶𝑉
(Eqn. 25.6.2)
𝐶𝑃,𝑠𝑝𝑟𝑎𝑦 𝑑𝑟𝑦𝑒𝑟 = exp (8.5133 + 0.9847 ln(𝑊) − 0.0561(ln(𝑊))2
(Eqn. 25.6.3)
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Table 25.6.1 Summary of Purchase Cost Calculation for a Fluid Bed Granulator
Parameters

Values

Granulation
Weight (kg)

6500

Weight (lb)

14,333

Cv ($)

59,272

FM

2

CP, granulator($)

118,543

Drying
Mass of evaporated water per batch (kg/batch)

304

Mass of evaporated water per batch (lb/batch)

669

Run time (hr)

6

Evaporation rate (lb/hr)

112

CP, spray dryer($)

148,510

CP, fluid bed granulator($)

267,053

25.6.1.2 Continuous Twin Screw Granulation and Fluid Bed Drying
For continuous granulation and drying, the correlations for a horizontal pressure vessel and
screw extruder were used. This is a flawed assumption as the granulator is not a pressure vessel.
For this calculation, the weight of the granulator is needed, and it was assumed the granulator
would weigh 6500lbs. For the screw extruder, the size factor is feed rate, F (lb/hr) with a range
of 8-800 lb/hr. Additionally, stainless steel is assumed as the material for the equipment, so the
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material factor FM was 2. The following equations were used to determine the purchase cost of
the twin screw granulator and fluid bed dryer.
𝐶𝑉,𝑔𝑟𝑎𝑛𝑢𝑙𝑎𝑡𝑜𝑟 = 𝑒𝑥𝑝(5.6336 + 0.4599(𝑙𝑛(𝑊)) + 0.00582(ln(𝑊))2
(Eqn. 25.6.4)
𝐶𝑃,𝑔𝑟𝑎𝑛𝑢𝑙𝑎𝑡𝑜𝑟 = 𝐹𝑀 𝐶𝑉
(Eqn. 25.6.5)
𝐶𝑃,𝑠𝑝𝑟𝑎𝑦 𝑑𝑟𝑦𝑒𝑟 = exp (10.9186 + 0.02099(ln(𝐹))2
(Eqn. 25.6.6)

Table 25.6.2 Summary of Purchase Cost Calculation for a Twin-Screw Granulator and Fluid
Bed Dryer
Parameters

Values

Granulation
Weight (kg)

6500

Weight (lb)

14332.5

Cv ($)

38872.02

FM

2

CP, granulator($)

77,744

Drying
Feed rate (kg/hr)

62.32

Feed rate (lb/hr)

137.4156

CP,dryer ($)

91,795
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25.6.2 Blender
For the blender in both the batch and continuous process, the correlation for the tumbler
(double cone) was used. However, a bin blender is used for the batch process and a continuous
blender that is tubular in design is used for the continuous process. Therefore, this correlation
does not correspond to the actual equipment being used in the processes. The size factor is
volume V (ft3) with a range of 10-380 ft3. The following equation is used to determine the
purchase cost of a blender.
𝐶𝑃 = 3856𝑉 0.42
(Eqn. 25.6.7)

Table 25.6.3 Summary of Purchase Cost Calculation for a Blender
Parameters

Values

Mass into blender (kg)

1920

Bulk Density(kg/L)

0.5

Volume (L)

3840

Volume (ft3)

136

CP ($)

30,318

25.6.3 Mill

For the mill in both the batch and continuous process, the correlation for the hammer mill
was used. However, the mill used in both processes was gentler and helped in delumping particle
agglomerates. Therefore, this correlation for the hammer mill, which is more aggressive than the
mill used in the processes, does not correspond to the equipment used in the processes. The size
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factor is feed rate W (tons/hr) with a range of 2-200 tons/hr. The following equation is used to
determine the purchase cost of a mill.
𝐶𝑃 = 4310𝑉 0.78
(Eqn. 25.6.8)

Table 25.6.4 Summary of Purchase Cost Calculation for a Mill
Parameters

Values

Feed rate (kg/hr)

64

Feed rate (lb/hr)

140.8

CP ($)

20,436

25.6.4 Tablet Press

For the tablet press in both the batch and continuous process, the correlation for the tablet
press was used. The size factor is feed rate F (lb/hr) with a range of 800-8,000 lb/hr. However,
the feed rates for both processes do not fall within this range. The following equation is used to
determine the purchase cost of a tablet press.
𝐶𝑃, = exp (9.2828 + 0.1050 ln(𝐹) − 0.01885(ln(𝐹))2
(Eqn. 25.6.9)
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Table 25.6.5 Summary of Purchase Cost Calculation for a Tablet Press for batch Process
Parameters

Values

Feed rate (kg/hr)

91

Feed rate (lb/hr)

201

CP($)

31,866

Table 25.6.6 Summary of Purchase Cost Calculation for a Tablet Press for continuous Process
Parameters

Values

Feed rate (kg/hr)

79

Feed rate (lb/hr)

174

CP($)

30,532

25.6.5 Batch and Continuous Coater

For the batch and continuous coater, the correlations for a vertical pressure vessel and
spray dryer were used. This is a flawed assumption as the granulator is not a pressure vessel. For
this calculation, the weight of the granulator is needed, and it was assumed the granulator would
weigh 6500lbs. For the spray dryer, the size factor is evaporation rate W(lb/hr) with a range of
30-3,000 lb/hr. Additionally, stainless steel is assumed as the material for the equipment, so the
material factor FM was 2.00. The following equations were used to determine the purchase cost
of the fluid bed granulator.
𝐶𝑉,𝑔𝑟𝑎𝑛𝑢𝑙𝑎𝑡𝑜𝑟 = 𝑒𝑥𝑝(7.1390 + 0.18255 ln(𝑊) + 0.02297(ln(𝑊))2
(Eqn. 25.6.10)
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𝐶𝑃,𝑔𝑟𝑎𝑛𝑢𝑙𝑎𝑡𝑜𝑟 = 𝐹𝑀 𝐶𝑉
(Eqn. 25.6.11)
𝐶𝑃,𝑠𝑝𝑟𝑎𝑦 𝑑𝑟𝑦𝑒𝑟 = exp (8.5133 + 0.9847 ln(𝑊) − 0.0561(ln(𝑊))2
(Eqn. 25.6.12)

Table 25.6.7 Summary of Purchase Cost Calculation for a Batch Coater
Parameters

Values

Coating
Weight (kg)

6500

Weight (lb)

14333

Cv

59,272

FM

2

CP,coating ($)

118,543

Drying
Mass of water evaporated (kg)

720

Run time (hr)

6

Evaporation rate (kg/hr)

120

Evaporation rate (lb/hr)

264.6

CP, coating dryer($)

24,283

Cp,coater($)

142,826
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Table 25.6.8 Summary of Purchase Cost Calculation for a Continuous Coater
Parameters

Values

Coating
Weight (kg)

6500

Weight (lb)

14,333

Cv

59,272

FM

2

CP,coating($)

118,543

Drying
Evaporation rate (kg/hr)

30

Evaporation rate (lb/hr)

66.15

CP, coating dryer($)

115,299

Cp,coater($)

233,842
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25.6.6 Equipment cost of conveyors.

The conveying distance between operations was taken to be 3 meters, and pneumatic
conveyors are used to convey the material between unit operations, except for the transfer from
the second blender to the tablet press, for which screw conveyors are used. Cost estimates for the
purchase price of conveyers are found using the following equations.

For pneumatic conveyors, where M is the solids flow rate and L is the conveying length:
𝐶𝑃 = 17,240𝑀0.63 𝐿0.2
(Eqn. 25.6.13)

For screw conveyors, where D is the diameter of screws and L is conveying length:
𝐶𝑃 = 80𝐷𝐿0.59
(Eqn. 25.6.14)
Section 25.7 Bare Module Costs Equation
The following equation is used to calculate the bare module cost.
𝐶𝐵𝑀 = 𝐹𝐵𝑀 𝐶𝑝
(Eqn. 25.7.1)
Section 25.8 Cash Flow Model
The following equations were used to calculate the cash flow.
During construction years:
𝐶𝐹 = −𝑓𝐶𝑇𝐷𝐶 − 𝐶𝑊𝐶
(Eqn. 25.8.1)
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During product manufacturing years:
𝐶𝐹 = (1 − 𝑡)(𝑆 − 𝐶) + 𝐷
(Eqn. 25.8.2)
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Year
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
2032
2033
2034
2035
2036
2037
2038
2039
2040
2041
2042
2043
2044

Percentage of Product Unit
Design Capacity
Price
0%
0%
90%
$15.38
90%
$15.38
90%
$15.38
90%
$15.38
90%
$15.38
90%
$15.38
90%
$15.38
90%
$15.38
90%
$15.38
90%
$15.38
90%
$15.38
90%
$15.38
90%
$15.38
90%
$15.38
90%
$15.38
90%
$15.38
90%
$15.38
90%
$15.38
90%
$15.38
90%
$15.38
90%
$15.38
9,135,700
9,135,700
9,135,700
9,135,700
9,135,700
9,135,700
9,135,700
9,135,700
9,135,700
9,135,700
9,135,700
9,135,700
9,135,700
9,135,700
9,135,700
9,135,700
9,135,700
9,135,700
9,135,700
9,135,700
9,135,700

Sales
(31,142,500)
-

Capital Costs

Working Capital
(479,400)
479,400
(1,130,300)
(1,130,300)
(1,130,300)
(1,130,300)
(1,130,300)
(1,130,300)
(1,130,300)
(1,130,300)
(1,130,300)
(1,130,300)
(1,130,300)
(1,130,300)
(1,130,300)
(1,130,300)
(1,130,300)
(1,130,300)
(1,130,300)
(1,130,300)
(1,130,300)
(1,130,300)
(1,130,300)

Var Costs

Fixed Costs Depreciation
(6,495,800)
(5,055,600)
(6,495,800)
(8,089,000)
(6,495,800)
(4,853,400)
(6,495,800)
(2,912,000)
(6,495,800)
(2,912,000)
(6,495,800)
(1,456,000)
(6,495,800)
(6,495,800)
(6,495,800)
(6,495,800)
(6,495,800)
(6,495,800)
(6,495,800)
(6,495,800)
(6,495,800)
(6,495,800)
(6,495,800)
(6,495,800)
(6,495,800)
(6,495,800)
(6,495,800)
-

Cash Flow Summary
Depletion
Allowance
-

Taxible Income
(3,546,000)
(6,579,300)
(3,343,700)
(1,402,400)
(1,402,400)
53,600
1,509,700
1,509,700
1,509,700
1,509,700
1,509,700
1,509,700
1,509,700
1,509,700
1,509,700
1,509,700
1,509,700
1,509,700
1,509,700
1,509,700
1,509,700

Table 25.8.1 Cash Flow Model for the Batch Process ($0.01/tablet)

815,600
1,513,200
769,100
322,500
322,500
(12,300)
(347,200)
(347,200)
(347,200)
(347,200)
(347,200)
(347,200)
(347,200)
(347,200)
(347,200)
(347,200)
(347,200)
(347,200)
(347,200)
(347,200)
(347,200)

Taxes

Net Earnings
(2,730,400)
(5,066,100)
(2,574,700)
(1,079,800)
(1,079,800)
41,300
1,162,400
1,162,400
1,162,400
1,162,400
1,162,400
1,162,400
1,162,400
1,162,400
1,162,400
1,162,400
1,162,400
1,162,400
1,162,400
1,162,400
1,162,400

Cash Flow
(31,621,900)
2,325,200
3,022,900
2,278,700
1,832,200
1,832,200
1,497,300
1,162,400
1,162,400
1,162,400
1,162,400
1,162,400
1,162,400
1,162,400
1,162,400
1,162,400
1,162,400
1,162,400
1,162,400
1,162,400
1,162,400
1,641,800

Cumulative Net Present
Value at 15%
(27,497,300)
(25,739,100)
(23,751,500)
(22,448,600)
(21,537,700)
(20,745,600)
(20,182,700)
(19,802,700)
(19,472,300)
(19,184,900)
(18,935,100)
(18,717,800)
(18,528,900)
(18,364,600)
(18,221,800)
(18,097,500)
(17,989,500)
(17,895,600)
(17,813,900)
(17,742,900)
(17,681,100)
(17,605,300)
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Year
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
2032
2033
2034
2035
2036
2037
2038
2039
2040
2041
2042
2043
2044

Percentage of Product Unit
Design Capacity Price
0%
0%
90%
$15.38
90%
$15.38
90%
$15.38
90%
$15.38
90%
$15.38
90%
$15.38
90%
$15.38
90%
$15.38
90%
$15.38
90%
$15.38
90%
$15.38
90%
$15.38
90%
$15.38
90%
$15.38
90%
$15.38
90%
$15.38
90%
$15.38
90%
$15.38
90%
$15.38
90%
$15.38
90%
$15.38
8,997,300
8,997,300
8,997,300
8,997,300
8,997,300
8,997,300
8,997,300
8,997,300
8,997,300
8,997,300
8,997,300
8,997,300
8,997,300
8,997,300
8,997,300
8,997,300
8,997,300
8,997,300
8,997,300
8,997,300
8,997,300

Sales

Working Capital
Var Costs
Fixed Costs Depreciation
(23,893,700)
(374,700)
(1,152,000) (5,081,200) (3,878,800)
(1,152,000) (5,081,200) (6,206,200)
(1,152,000) (5,081,200) (3,723,700)
(1,152,000) (5,081,200) (2,234,200)
(1,152,000) (5,081,200) (2,234,200)
(1,152,000) (5,081,200) (1,117,100)
(1,152,000) (5,081,200)
(1,152,000) (5,081,200)
(1,152,000) (5,081,200)
(1,152,000) (5,081,200)
(1,152,000) (5,081,200)
(1,152,000) (5,081,200)
(1,152,000) (5,081,200)
(1,152,000) (5,081,200)
(1,152,000) (5,081,200)
(1,152,000) (5,081,200)
(1,152,000) (5,081,200)
(1,152,000) (5,081,200)
(1,152,000) (5,081,200)
(1,152,000) (5,081,200)
374,700
(1,152,000) (5,081,200)
-

Capital Costs

Cash Flow Summary
Depletion
Allowance
-

Taxible Income
(1,114,700)
(3,442,000)
(959,600)
529,900
529,900
1,647,000
2,764,100
2,764,100
2,764,100
2,764,100
2,764,100
2,764,100
2,764,100
2,764,100
2,764,100
2,764,100
2,764,100
2,764,100
2,764,100
2,764,100
2,764,100
256,400
791,700
220,700
(121,900)
(121,900)
(378,800)
(635,700)
(635,700)
(635,700)
(635,700)
(635,700)
(635,700)
(635,700)
(635,700)
(635,700)
(635,700)
(635,700)
(635,700)
(635,700)
(635,700)
(635,700)

Taxes

Net Earnings Cash Flow
(24,268,400)
(858,300)
3,020,500
(2,650,400)
3,555,800
(738,900)
2,984,800
408,000
2,642,200
408,000
2,642,200
1,268,200
2,385,300
2,128,400
2,128,400
2,128,400
2,128,400
2,128,400
2,128,400
2,128,400
2,128,400
2,128,400
2,128,400
2,128,400
2,128,400
2,128,400
2,128,400
2,128,400
2,128,400
2,128,400
2,128,400
2,128,400
2,128,400
2,128,400
2,128,400
2,128,400
2,128,400
2,128,400
2,128,400
2,128,400
2,128,400
2,128,400
2,503,100

Table 25.8.2 Cash Flow Model for the Continuous Process ($0.01/tablet)

Cumulative Net Present
Value at 15%
(21,103,000)
(18,819,100)
(16,481,100)
(14,774,500)
(13,460,800)
(12,318,500)
(11,421,800)
(10,726,000)
(10,121,000)
(9,594,900)
(9,137,500)
(8,739,600)
(8,393,700)
(8,092,900)
(7,831,400)
(7,603,900)
(7,406,100)
(7,234,200)
(7,084,600)
(6,954,600)
(6,841,500)
(6,725,800)

Section 25.9 Profitability Measures
The following equation was used to determine ROI:
𝑅𝑂𝐼 =

𝑁𝑒𝑡 𝐸𝑎𝑟𝑛𝑖𝑛𝑔𝑠
𝑇𝑜𝑡𝑎𝑙 𝐶𝑎𝑝𝑖𝑡𝑎𝑙 𝐼𝑛𝑣𝑒𝑠𝑡𝑚𝑒𝑛𝑡
(Eqn. 25.9.1)
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Section 25.10 Equipment Brochures
25.10.1 Glatt Fluid Bed Granulator/Dryer
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25.10.2 Glatt Continuous Line
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25.10.3. Thermo Fisher Twin Screw Granulator
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25.10.4. Verderflex Pump Brochure
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25.10.5 Quadro FlexSift S20 brochure
It should be noted that although the power for the FlexSift S20 in the brochure is 5.6 kW, the
value used in calculations for the batch process was 3.73 kW as the latter value was obtained
from a call with a Quadro sales representative. The value used in calculations for the continuous
process was 0.55 kW as the throughput for the continuous process is much lower than that for the
batch process. The price of the equipment was also obtained from a call with Quadro sales
representative.
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25.10.6 LB Bohle container blender (PM-6000) brochure
The price of this blender was obtained from emails with an LB Bohle sales representative.
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25.10.7 Gericke continuous blender (GCM-450) brochure
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25.10.8 Thomas Engineering Accela-Cota Pro Brochure
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25.10.9 Suteric Aqueous Enteric coating system Technical Data Sheet
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25.10.10 Thomas Engineering FLEX CTC Continuous Tablet Coating System Brochure
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25.10.11 Continuous Coater Applications Publication
This publication was obtained from a representative from Thomas Engineering. Here only part of
the publication is included. This publication was used to obtain information for the temperatures
of the streams going into and leaving TC-1(C)
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